MedWorm: Cancer & Oncology News

Nigeria: Achieving Cervical Cancer-Free Generation

AllAfrica News: Health and Medicine — Thu, 06 Jun 2024 21:17:47 +0100

[Leadership] Fourteen-year-old Miss Damillola John referred to her day of receiving the Human Papillomavirus (HPV) vaccine as one of her best moments ever. (Source: AllAfrica News: Health and Medicine)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

ASCO 2024: What's New in Breast Cancer Research? ASCO 2024: What's New in Breast Cancer Research?

Medscape Today Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Drs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.Medscape Oncology (Source: Medscape Today Headlines)

Liverpool Council probing potential cancer cluster after five women working metres from each other became ill

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

The council has engaged a third-party environmental health consultant while the Health department runs a separate investigation. (Source: the Mail online | Health)

Revealed: The popular drinks that contain taurine - after ingredient was linked to colon cancer in young people

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

As an upcoming trial suggests that taurine is linked to rising causes of colon cancer in young people, DailyMail.com reveals seven of the most popular drinks containing taurine. (Source: the Mail online | Health)

Intimate and embarrassing women's health problems answered by doctors - from lumps and itches to the red-flag signs of cancer you must not ignore

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

From rashes to lumps, odours to dryness, redness, itching and more, there are many intimate health complaints that can affect women, and often the symptoms can be easy to confuse. (Source: the Mail online | Health)

Prosecutors' star witness takes stand in Hunter Biden trial

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

What to know about Hallie Biden Hallie Biden has taken the witness stand. She is the wife of the late Beau Biden, Hunter Biden's older brother, who died from brain cancer in 2015. Hunter Biden began a romantic relationship with Hallie Biden and they were together at the time that Hunter Biden…#beaubiden #hunterbiden #halliebiden #derekhines #abbelowell #lowell #hines #wilmington #atf #abbelowells (Source: Reuters: Health)

MedWorm Message:

Abemaciclib Combo Improves Survival in Breast Cancer Abemaciclib Combo Improves Survival in Breast Cancer

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Abemaciclib plus fulvestrant improved progression-free survival in certain patients with advanced breast cancer, new data showed.MDedge News (Source: Medscape Hematology-Oncology Headlines)

Transplant in Unresectable Colorectal Liver Metastases? Transplant in Unresectable Colorectal Liver Metastases?

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Liver transplant plus chemotherapy offers a potential cure for carefully selected patients with unresectable colorectal liver metastases, new data suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

This biologist aims to solve the cell ’s biggest mystery. Could it help cancer patients, too?

ScienceNOW — Thu, 06 Jun 2024 21:17:47 +0100

LEONARD ROME SWITCHES OFF the overhead light in the small room, leaving it illuminated only by a computer monitor and the fluorescent screen at the base of a towering electron microscope. Qing Lou, a Ph.D. student who works with the University of California, Los Angeles (UCLA) biologist, points to some ovoid smudges within the circular green glow of the microscope display. With a twist of a dial and a click of a mouse, she brings the shadows into focus and snaps a picture. Dozens, maybe hundreds, of barrel-shaped particles suddenly fill the computer monitor. “There they are,” Rome says, like a proud father showing off his children. These are vaults, enigmatic cellular structures that he and his then-postdoc Nancy Kedersha discovered back in 1986 , when Rome was a new...

Charity accused of 'insulting women' with claim ovarian cancer can strike 'any gender'

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Ovarian Cancer Action posted on X: "Did you know that anyone with ovaries, regardless of gender identity, can be at risk for ovarian cancer?" (Source: Daily Express - Health)

' Groundbreaking' Lung Cancer Trial Shows Survival Benefits'Groundbreaking' Lung Cancer Trial Shows Survival Benefits

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The ADRIATIC trial found that adding durvalumab to consolidation treatment increased progression-free survival and added 2 years of life in patients with limited stage small cell lung cancer.MDedge News (Source: Medscape Hematology-Oncology Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Rural Patients With Melanoma Fare Worse Than Urban Dwellers Rural Patients With Melanoma Fare Worse Than Urban Dwellers

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The findings come from an analysis of Surveillance, Epidemiology, and End Results (SEER) data over 20 years.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Certain mouthwash could be raising your risk of cancer and other disease, scientists warn

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Long-term use of this mouthwash "should be guided by healthcare professionals", an expert warned. (Source: Daily Express - Health)

Zimbabwe: Machines Boost for Cancer Patients

AllAfrica News: Health and Medicine — Thu, 06 Jun 2024 21:17:47 +0100

[The Herald] The Government has partnered a supplier of cancer treatment equipment at Parirenyatwa Group of Hospitals and Mpilo Central Hospital to repair machines that have been out of service for about two years. (Source: AllAfrica News: Health and Medicine)

Ultrasound Device Delivers Meds to Better Fight Brain Tumors

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

THURSDAY, June 6, 2024 -- One of the biggest obstacles to treating brain cancer is getting tumor-killing drugs past the blood-brain barrier that normally protects the brain from foreign invaders.Now, new research shows that ultrasound waves emitted... (Source: Drugs.com - Daily MedNews)

‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.

Washington Post: To Your Health — Thu, 06 Jun 2024 21:17:47 +0100

It ’s not a new idea that viruses can cause or accelerate cancer. But it will probably be years before answers emerge about covid and cancer. (Source: Washington Post: To Your Health)

MedWorm Message:

Young People's Gut Bacteria May Drive Colorectal Cancer Risk Young People's Gut Bacteria May Drive Colorectal Cancer Risk

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The rate of colorectal cancer among young people has been rising at an alarming rate, according to a 2023 report from the American Cancer Society.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)

Unsafe food makes 100 million people ill each year in the Region

WHO EMRO News — Thu, 06 Jun 2024 21:17:47 +0100

7 June 2024, Cairo, Egypt – “Prepare for the unexpected” is the theme of the sixth World Food Safety Day, marked today by the United Nations. Food businesses, governments and consumers can all help prevent food contamination and foodborne illnesses. Food must be protected at every stage from production to consumption. WHO and the Food and Agriculture Organization of the United Nations (FAO) jointly facilitate the international day to raise awareness of this issue globally. The Eastern Mediterranean Region bears a substantial burden of foodborne diseases. According to WHO estimates from 2015, 100 million people living in the Region experience foodborne illnesses each year – 32 million of those cases are children aged under 5 years. Foodborne diarrhoeal diseases caused by pathogen...

Neoadjuvant Nivolumab, Ipilimumab Safe for dMMR Colon Cancer

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

WEDNESDAY, June 5, 2024 -- Neoadjuvant nivolumab plus ipilimumab has an acceptable safety profile in patients with locally advanced mismatch repair-deficient (dMMR) colon cancer, according to a study published in the June 6 issue of the New England... (Source: Drugs.com - Pharma News)

Doctor reveals real reason you're always bloated – and signs to look out for

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Bloating is a common issue that can be extremely uncomfortable, but it could also be a warning sign of something more serious - such as ovarian cancer. (Source: Daily Express - Health)

Race Oncology Issues New Options for Growth

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Race Oncology Ltd. (AU:RAC) has released an update. Race Oncology Ltd has announced the issue of 1,919,859 new options, set to expire on May 29, 20...#raceoncologyltd #rac (Source: Reuters: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Race Oncology Seeks ASX Quotation Expansion

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Race Oncology Ltd. (AU:RAC) has released an update. Race Oncology Ltd has announced the application for quotation of 641,804 new ordinary fully pai...#raceoncologyltd #rac (Source: Reuters: Health)

Metformin Fails to Stop Early Prostate Cancer Progression

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Use of metformin didn't prevent progression of low-risk localized prostate cancer in patients on active surveillance, according to data from the randomized MAST study. There was no statistically significant difference... (Source: MedPage Today Hematology/Oncology)

New Mexico hospital refuses to treat CANCER patients unless they pay thousands up front for lifesaving treatments

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Cancer patients in New Mexico are among the growing number of sick people across the country being asked to fork over thousands of dollars for treatments they hadn't yet received. (Source: the Mail online | Health)

CML: Asciminib Bests Standard TKIs as Frontline Therapy CML: Asciminib Bests Standard TKIs as Frontline Therapy

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Asciminib demonstrated efficacy vs standard-of-care frontline TKIs in newly diagnosed patients with CML.MDedge News (Source: Medscape Hematology-Oncology Headlines)

Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

WALTHAM, Mass. and DUBLIN, June 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc MURA, a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that…#waltham #mass #dublin #muraloncologyplc #carolineloew #phd #ideasconferences #nfjinvestmentgroup #arielinvestments #diamondhill (Source: Reuters: Health)

MedWorm Message:

'Can men get ovarian cancer?': Charity sparks fury after claiming anyone can get the disease 'regardless of gender'

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Ovarian Cancer Action sparked fury with its tweet, which featured the LGBT+ rainbow flag and said: 'Let's raise awareness by asking: Can men get ovarian cancer?' (Source: the Mail online | Health)

Food insecurity tied to lower likelihood of mammography screening

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Women with food insecurity are less likely to report attending mammography screening, according to research published June 3 in the Journal of the American College of Radiology. A team led by Jerome Phillip Watts from Howard University in Washington, DC, found in a nationally representative cross-sectional survey that women classified as having low or very low food security were significantly less likely to undergo mammography than women reporting high or marginal food security. “Understanding social risk factors and addressing social needs can help radiology practices and healthcare systems increase cancer screening among historically underserved patient populations,” Watts and colleagues wrote. Radiology researchers have explored the potential roles of social determinants of healt...

Exploring Applications of CAR-T Therapy Outside Oncology: Strategies for Applying Lessons Learned, Upcoming Webinar Hosted by Xtalks

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

In this webinar, learn about the nature of CAR-T therapy and how the transition from oncology to non-oncology indications presents challenges and complexities in running clinical trials. Attendees will understand the latest developments shaping oncology research and future prospects in... (Source: PRWeb: Medical Pharmaceuticals)

Four sodas sold in restaurants across the US are recalled by FDA for containing hidden cancer-causing food dye

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Undeclared dangerous food dyes Red 40 and Yellow 5 were found in the drinks. Both contain benzidine, a human and animal carcinogen. (Source: the Mail online | Health)

Scientists look to cancer drug to treat bowel disease

FT.com - Drugs and Healthcare — Thu, 06 Jun 2024 21:17:47 +0100

‘Gene desert’ research boosts knowledge of chronic disease mechanisms and promises to unlock novel therapies (Source: FT.com - Drugs and Healthcare)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

S2 Episode 3: How Do You Treat Refractory Colorectal Cancer? S2 Episode 3: How Do You Treat Refractory Colorectal Cancer?

Medscape General Surgery Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Join Drs Benjamin Schlechter and Cathy Eng as they discuss the treatments and clinical trials available for patients with refractory colorectal cancer.Medscape (Source: Medscape General Surgery Headlines)

ASCO: Osimertinib Improves Progression-Free Survival in EGFR-Mutated Lung Cancer

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

WEDNESDAY, June 5, 2024 -- For patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC), treatment with osimertinib results in significantly longer progression-free survival, according to a study published online June 2... (Source: Drugs.com - Pharma News)

Scientists identify ‘missing piece’ required for blood stem cell self-renewal

UCLA Newsroom: Health Sciences — Thu, 06 Jun 2024 21:17:47 +0100

Key takeawaysBlood stem cells – key to transplants that are used as life-saving treatments for blood cancers and blood and immune disorders – have the capacity to self-renew, but quickly lose their ability to do so in a lab dish.UCLA scientists have identified a protein that not only enables blood stem cells to self-renew in a lab dish, but also allows these expanded cells to function effectively after being transplanted into mouse models. The findings could help make blood stem cell transplants available to more people and improve the accessibility and safety of gene therapies that use these cells.UCLA scientists have identified a protein that plays a critical role in regulating human blood stem cell self-renewal by helping them sense and interpret signals from their environment.T...

Illumina to spin off early cancer detection test maker Grail after ill-fated $8 billion acquisition

bizjournals.com Health Care:Biotechnology headlines — Thu, 06 Jun 2024 21:17:47 +0100

Grail was planning an IPO before Illumina started the process of buying it, leading to regulatory actions and now a spinout. (Source: bizjournals.com Health Care:Biotechnology headlines)

Docetaxel Tied to Less Taxane Neuropathy in Black Breast Cancer Patients

MedPage Today Public Health — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Germline variations did not predict the risk of taxane-induced peripheral neuropathy (TIPN) in a phase II trial involving Black women with early-stage breast cancer, but the researchers found that docetaxel was associated... (Source: MedPage Today Public Health)

MedWorm Message:

Four red flag symptoms of ‘preventable’ silent killer cancer to spot

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

If you notice any of these concerning signs you should speak to your GP. (Source: Daily Express - Health)

Sarah Ferguson praises " courageous " Princess Kate after cancer diagnosis

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Princess Kate is an "inspiration" in how she has handled her cancer diagnosis and treatment on the world stage, Prince Andrew's ex-wife, Sarah "Fergie" Ferguson, the Duchess of York, has said. The duchess, who was diagnosed with breast cancer in 2023 and skin cancer in January 2024, praised Kate…#princeandrew #fergie #duchessofyork #loosewomen #buckinghampalace #charlesiii #kensingtonpalace #portsmouth #worldwarii #queencamilla (Source: Reuters: Health)

Diagnosing Cancer in the ED'Becoming Routine' in Canada Diagnosing Cancer in the ED'Becoming Routine' in Canada

Medscape Medical News Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Emergency physicians in Canada say that cancer diagnoses are often given in the emergency department, which takes a toll on clinicians and patients.Medscape Medical News (Source: Medscape Medical News Headlines)

ArriVent BioPharma ’s Strategic Alliance for Cancer Drug Development

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

An announcement from ArriVent BioPharma, Inc. (AVBP) is now available. ArriVent BioPharma has embarked on a groundbreaking venture with Jiangsu Alp...#arriventbiopharmainc #avbp #biopharma #jiangsualp (Source: Reuters: Health)

I-Mab and Bristol Myers Squibb Tackle Gastric Cancer

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

I-MAB (IMAB) has released an update. I-Mab has announced a partnership with Bristol Myers Squibb to explore a new combination treatment for gastric...#imab #bristolmyerssquibb (Source: Reuters: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Can-Fite Reports Progress in Liver Cancer Drug Trial

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Can-Fite BioPharma (CANF) has released an update. Can-Fite BioPharma has reported advancements in their pivotal Phase 3 study of Namodenoson for tr...#canfitebiopharma #canf #phase3 (Source: Reuters: Health)

ASCO: Thermal ablation comparable to surgery for liver metastases

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Treating colorectal cancer patients with small liver metastases with thermal ablation is comparable to surgical resection, a study presented June 3 at the American Society of Clinical Oncology (ASCO) meeting found. Using thermal ablation as the standard of care would benefit patients, presenter Martijn Ruben Meijerink, MD, PhD, from Amsterdam University Medical Center in the Netherlands, noted. Meijerink shared results from the Colorectal Liver Metastases: Surgery vs. Thermal Ablation (COLLISION) trial. “Transitioning … to thermal ablation as standard of care for patients with small-size [≤ 3 cm] colorectal liver metastases would reduce complications, shorten hospital stay, and improve local control without compromising disease-free and overall survival,” he said. There is growi...

Siemens integrates Lantheus ’ AI software in PET/CT platform

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Lantheus’ AI software aPromise for assessing prostate-specific membrane antigen PET/CT exams is now available on Siemens Healthineers’ syngo.via platform. aPromise is a U.S.-cleared deep learning algorithm that provides quantitative total disease burden on F-18 DCFPyL (Pylarify) PET/CT images. Recent clinical studies have shown that total quantitative burden with aPromise supports patient selection for prostate cancer radioligand therapy and automates monitoring response over time, Lantheus said. Siemens Healthineers will be demonstrating the integrated solution at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Toronto to be held June 8 to 11, Lantheus noted. (Source: AuntMinnie.com Headlines)

ASCO: Stepped-Care Model Noninferior to Early Palliative Care for Advanced Cancer

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, June 4, 2024 -- For patients with advanced lung cancer, a stepped-care model with palliative care visits occurring at key points in patients'cancer trajectory is noninferior to early palliative care, according to a study published online... (Source: Drugs.com - Pharma News)

Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Combining the anti-CD38 monoclonal antibody isatuximab (Sarclisa) with the standard backbone of bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (VRd) significantly improved outcomes in patients with... (Source: MedPage Today Hematology/Oncology)

MedWorm Message:

AAS Cycling for Prostate Cancer Prevention

eHealth News EU — Thu, 06 Jun 2024 21:17:47 +0100

There are many different studies on the effects of anabolic-androgenic steroids (AAS), and most of them seem to focus on the negative effects. Research has linked high blood pressure, liver damage, mood swings, and even prostate cancer to steroids. Despite the negatives, some studies may actually suggest that AAS cycling for prostate cancer prevention is possible.... The post AAS Cycling for Prostate Cancer Prevention appeared first on Anabolicco. (Source: eHealth News EU)

Now doctors face new cancer crisis - mystery rise of lung tumors in young people who've NEVER smoked

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Researchers presenting at the ASCO meeting in Chicago this weekend warned that lung cancer in young people is on the rise, despite youth smoking rates falling near an all-time low. (Source: the Mail online | Health)

AI Plus Mammograms Might Boost Breast Cancer Detection

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, June 4, 2024 -- Artificial intelligence (AI) can improve doctors’ assessments of mammograms, accurately detecting even the smallest breast cancers with fewer scary false positive readings, a new study shows. AI-assisted mammography... (Source: Drugs.com - Daily MedNews)

ctDNA Analysis Not Enough to Guide Chemo De-Escalation in Early Pancreatic Cancer

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- The use of circulating tumor (ct)DNA analysis following upfront surgery for early-stage pancreatic cancer to guide adjuvant chemotherapy de-escalation did not appear to influence outcomes, according to a prospective... (Source: MedPage Today Hematology/Oncology)

ctDNA Analysis Not Enough to Guide Treatment Decisions in Early Pancreatic Cancer

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- The use of circulating tumor (ct)DNA analysis following upfront surgery for early-stage pancreatic cancer to guide treatment decision making did not appear to influence outcomes, according to a prospective study... (Source: MedPage Today Hematology/Oncology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Erich Anderson, ‘Felicity’ and ‘Friday the 13th: The Final Chapter’ Actor, Dies at 67

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Erich Anderson, the familiar character actor who made his film debut in Friday the 13th: The Final Chapter, played Keri Russell‘s father on Felicity and recurred on shows from Steven Bochco, has died. He was 67. Anderson died Saturday after a “brutal struggle with cancer,” his wife, Saxon Trainor,…#erichanderson #kerirussells #stevenbochco #saxontrainor #michaelomalley #finalchapter #robdier #edwardporter #wb #bochco (Source: Reuters: Health)

Sanofi Highlights Data From Blood Cancer Drug Sarclisa In New Diagnosed Multiple Myeloma Patients

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Monday, Sanofi SA SNY shared data from the IMROZ phase 3 study of Sarclisa, which enrolled 446 patients with newly diagnosed, transplant-ineligible multiple myeloma. The company says that IMROZ is the first global phase 3 study of an anti-CD38 monoclonal antibody in combination with…#sanofisasny #sarclisa #ndmm #mrd #fda (Source: Reuters: Health)

A Win for Liver Transplantation in Unresectable Metastatic Colorectal Cancer

MedPage Today Gastroenterology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Liver transplantation for unresectable colorectal cancer (CRC) liver metastases led to dramatic improvement in long-term survival, French investigators reported. Five-year overall survival (OS) increased from 13... (Source: MedPage Today Gastroenterology)

Colon cancer crisis in young people could be fueled by booming drinks brands adored by teens

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

They are used by millions of workers to power through afternoon slumps. But highly caffeinated energy drinks could be partly fueling the explosion of colorectal cancers in young people. (Source: the Mail online | Health)

Weight loss jabs like Ozempic and Wegovy cut risk of bowel cancer by half - and boost breast cancer survival by a third, study suggests

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Doctors say it will be the 'icing on the cake' if the medicines, which have been shown to cut heart attack and strokes, had a comparable effect on cancer. (Source: the Mail online | Health)

MedWorm Message:

Weight loss jabs have 'enormous potential' to cut risk of obesity-related cancers

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

The revolutionary jabs were a hot topic as more than 40,000 cancer experts gathered in Chicago for the world's largest cancer conference. (Source: Daily Express - Health)

‘Enormous potential’: weight-loss drugs cut cancer risk by a fifth, research shows

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

Experts believe injections such as Wegovy could play a big role in preventing and treating the diseaseWeight-loss drugs offer a new weapon in the global fight against cancer, with “enormous potential” to prevent new cases and shrink tumours, doctors said as research showed the jabs can cut the risk of developing the disease by a fifth.Blockbuster injections such as Wegovy have revolutionised the treatment of obesity, and recently been approved for use in other areas of medicine, including reducing the risk of heart attacks, strokes and cardiovascular-related deaths.Continue reading... (Source: Guardian Unlimited Science)

New Drug Effective for Tenosynovial Giant Cell Tumors, and With No Liver Concerns

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- An oral investigational agent effectively shrank tenosynovial giant cell tumors (TGCTs) while demonstrating functional and symptomatic benefits for patients, the phase III MOTION trial showed. In 83 patients with... (Source: MedPage Today Hematology/Oncology)

Gastrectomy for Gastric Cancer Tied to Lower Risk for Cardiovascular Events

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, June 4, 2024 -- Patients with gastric cancer who undergo gastrectomy have a lower risk for cardiovascular events than the general population, according to a study published online March 28 in the International Journal of Surgery. Yeongkeun... (Source: Drugs.com - Pharma News)

Join Us in Recognizing National Black Family Cancer Awareness Week

FDA Center for Drug Evaluation and Research - What's New — Thu, 06 Jun 2024 21:17:47 +0100

Join the “4th Annual National Black Family Cancer Awareness Week, Engaging the Generations” initiative and the #BlackFamCan social media campaign this year, June 13-19. The event is virtual and open to the public. (Source: FDA Center for Drug Evaluation and Research - What's New)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Experts reveal key reasons behind concerning rise of colon cancer in young people

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Poor eating habits may be at the root of the concerning rise of cancer diagnosis among people under 50 years old, according to a recent study. (Source: Daily Express - Health)

Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Clinical activity and survival outcomes improved with the addition of ipilimumab (Yervoy) to nivolumab (Opdivo) in patients with ovarian or other gynecologic clear cell carcinomas, according to results from the non... (Source: MedPage Today Hematology/Oncology)

RSNA: AI Detects More Breast Cancers with Fewer False Positives

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

Using artificial intelligence (AI), breast radiologists in Denmark have improved breast cancer screening performance and reduced the rate of false-positive findings. Results of the study were published today in Radiology, a journal of the Radiological Society of North America (RSNA). OAK... (Source: PRWeb: Medical Pharmaceuticals)

AI reduces breast radiologist workload, false-positive cases

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

AI reduces breast radiologist workload while also improving screening performance and decreases the number of false-positive findings, according to a study published June 4 in Radiology. A team led by Andreas Lauritzen, PhD, from the University of Copenhagen in Denmark found that the commercially available AI system used in a population-based mammography study led to a 20% decrease in the recall rate and a 33% decrease in reading workload. “I think [AI] will add a lot of value to the radiologists themselves, where they have the tools and they can see markings from the AI,” Lauritzen told AuntMinnie.com. "They can prioritize their time and resources to the cases that actually matter." Retrospective studies have suggested that using AI can lessen the burden radiologists face when inte...

IRS Sues Controversial Doctor; Congresswoman Has Cancer; Caffeine and Teens

MedPage Today Public Health — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- Note that some links may require registration or subscription. The IRS sued Sherri Tenpenny, DO, an Ohio doctor who claimed COVID vaccines magnetized people, for $650,000 in federal taxes and late fees she has not paid. (AP... (Source: MedPage Today Public Health)

MedWorm Message:

Have doctors cracked mystery of rising cancer cases in young people? Low-fiber diets and too much sugar to blame for surging rates, say experts

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

The new research was presented this weekend at the American Society of Clinical Oncology meeting in Chicago. (Source: the Mail online | Health)

Have doctors cracked mystery of rising cancer cases in young people? Low fiber diets and too much sugar to blame for surging rates, say experts

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

The new research was presented this weekend at the American Society of Clinical Oncology meeting in Chicago. (Source: the Mail online | Health)

Study Examines Merkel Cell Carcinoma in Non-White Hispanics Study Examines Merkel Cell Carcinoma in Non-White Hispanics

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The findings underscore " the importance of considering race/ethnicity in understanding the epidemiology of this rare but increasingly prevalent cancer, " Borda said.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Very Early Menopause Could Raise Odds for Breast, Ovarian Cancers

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, June 4, 2024 -- Menopause before the age of 40 could raise a woman's long-term risk for breast or ovarian cancers, new research suggests. Besides that, " there is also higher risk of breast, prostate and colon cancer in relatives of these... (Source: Drugs.com - Daily MedNews)

Chemo Before, After Surgery Could Help Those Battling Esophageal Cancer

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, June 4, 2024 (Healthday News) -- People battling advanced esophageal cancers should get doses of chemotherapy both before and after tumor-removing surgeries, a new study suggests.“There is considerable disagreement as to whether... (Source: Drugs.com - Daily MedNews)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Telehealth for Cancer Care Helps Patients, Planet

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, June 4, 2024 -- Telemedicine visits for cancer care could help save the planet while also making things easier on patients, a new study has found. Nationwide, cancer care could generate 33% less greenhouse gas emissions if it shifted to... (Source: Drugs.com - Daily MedNews)

Red Flags for Early-Onset Colorectal Cancer Identified Red Flags for Early-Onset Colorectal Cancer Identified

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The most common presenting signs and symptoms of early-onset colorectal cancer include rectal bleeding, abdominal pain, and altered bowel habits, a new analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Cheap Drug Eases Hot Flashes in Men With Prostate Cancer

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- A widely available anticholinergic significantly improved hot flash symptoms in men taking androgen deprivation therapy (ADT) for their prostate cancer, a researcher reported here. In a double-blind randomized trial... (Source: MedPage Today Hematology/Oncology)

‘All American’ Says Goodbye To Kamar De Los Reyes’ Coach Montes

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

All American gave a proper goodbye to the late Kamar de los Reyes during Monday night’s episode. The actor, who died in December after a brief battle with cancer, joined the cast in Season 4 as Coastal California’s Coach Montes on the CW series. He appeared in the Season 6 premiere, but that was…#kamardelosreyes #codychristians #asheradams #coach #nfl #coachmontes #season7 (Source: Reuters: Health)

Why a Mastectomy may not work as well as just removing the lump

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

A mastectomy is often seen as the surest way to stop breast cancer recurring. But latest research suggests women live longer if just the tumour is removed rather than the whole breast. (Source: the Mail online | Health)

MedWorm Message:

" I Was Offered Assisted Dying Over Cancer Treatment " : Broken Canadian Healthcare System Is Killing Patients

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

"I Was Offered Assisted Dying Over Cancer Treatment": Broken Canadian Healthcare System Is Killing Patients Authored by Ian Birrell via UnHerd, Allison Ducluzeau with her doctor after receiving treatment. Two years ago, over the Thanksgiving holiday, Allison Ducluzeau started to feel pain in her…#ianbirrell #unherd #allisonducluzeau #ct #vancouverisland #victoria #taiwan #baltimore #britishcolumbia #hawaii (Source: Reuters: Health)

Doctors reveal deadly diet combos that could be causing explosion of colon cancers in young people

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Researchers may be one step closer to unravelling the cause of a colon cancer crisis in relatively young people. (Source: the Mail online | Health)

New skin cancer vaccine being trialled by the NHS can halve the risk of dying or the deadly disease returning, study finds

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Melanoma patients given Tecemotide alongside immunotherapy drug Keytruda were 49 per cent more likely to be alive three years later compared to those taking Keytruda alone. (Source: the Mail online | Health)

J & J must pay $260 million in latest talc trial, Oregon jury says

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Johnson & Johnson must pay $260 million to an Oregon woman who said she got mesothelioma, a deadly cancer linked to asbestos exposure, from inhaling the company's talc powder, a jury found on Monday. The verdict in the 4th Judicial District Circuit Court in Portland comes as the company continues…#johnsonjohnson #oregon #portland #erikhaas #kyunglee (Source: Reuters: Health)

Gene variants and breast cancer risk in Black women

NIH Research Matters from the National Institutes of Health (NIH) — Thu, 06 Jun 2024 21:17:47 +0100

In the largest study of its kind, researchers identified genetic variants that appear to boost breast cancer risk among females of African ancestry. (Source: NIH Research Matters from the National Institutes of Health (NIH))

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Doctors reveal deadly diet combos that could be causing explosion of colon cancers in young people

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

The new research was presented this weekend at the American Society of Clinical Oncology meeting in Chicago. (Source: the Mail online | Health)

First-Line Biparametric MRI Less Cost-Effective Than PSA for Prostate Cancer Screening

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

MONDAY, June 3, 2024 -- From an economic perspective, first-line prostate-specific antigen (PSA) testing is favored over biparametric magnetic resonance imaging (bpMRI) for prostate cancer screening, mainly due to false-positive results and... (Source: Drugs.com - Pharma News)

'Exciting' skin cancer vaccine halves risk of relapse or death in study

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

NHS patients are currently taking part in a global trial of the personalised vaccine. (Source: Daily Express - Health)

NHS skin cancer vaccine halves risk or dying or disease returning, study shows

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

In the longest study yet, melanoma patients given the personalised vaccine alongside the immunotherapy drug Keytruda were half more likely to be alive three years later. (Source: the Mail online | Health)

‘Extremely impressive’: melanoma jab trial results excite doctors

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

The new vaccine approach will help improve survival rates for ‘the next decades and more’, says Cancer Research UK’s chief clinicianThe world ’s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease returning, according to trial results that doctors described as “extremely impressive”.Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International.Continue reading... (Source: Guardian Unlimited Science)

MedWorm Message:

Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Consolidation treatment with durvalumab (Imfinzi) following concurrent chemoradiotherapy significantly improved both overall survival (OS) and progression-free survival (PFS) in patients with limited-stage small... (Source: MedPage Today Hematology/Oncology)

Mika Health, Cancer Support Community partner on AI oncologic digital therapeutic

mobihealthnews — Thu, 06 Jun 2024 21:17:47 +0100

Cancer patients and caregivers will receive free access to an AI-enabled app for mental health and other support services. (Source: mobihealthnews)

Why Is German Biotech Affimed Stock Soaring On Monday?

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Affimed N.V. AFMD shares are trading higher on Monday. On Saturday, the company announced longer follow-up data from the EGFRwt cohort and initial clinical efficacy data from the EGFRmut cohort from the ongoing AFM24-102 study in non-small cell lung cancer (NSCLC). As of the updated data cutoff on…#nsclc #median #afm24 (Source: Reuters: Health)

Real-World Research Presented at ASCO 2024 Indicates Clinical Trial Participation by Older Adults with Cancer Does Not Affect Emergency Room Visits or Hospice Enrollment

McKesson News — Thu, 06 Jun 2024 21:17:47 +0100

THE WOODLANDS, Texas, June 3, 2024, 1:15 p.m. CDT — To address a gap in knowledge surrounding clinical trial participation impacts on unplanned healthcare utilization and hospice enrollment in adults with cancer, investigators from The US Oncology Network (The Network), the largest organization of i ... (Source: McKesson News)

Drug that ‘melts away’ tumours hailed as ‘gamechanger’ for some bowel cancer patients

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

Pembrolizumab triples chance of survival for the 10-15% of patients with the right genetic makeup, study findsA “gamechanger” immunotherapy drug that “melts away” tumours dramatically increases the chances of curing some bowel cancers and may even replace the need for surgery, doctors have said.Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells.Continue reading... (Source: Guardian Unlimited Science)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Merck's 3-pronged cancer strategy stars Moderna-partnered vaccine

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

As Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on three strategies. One of those prongs is improving immune responses, a pillar that stars Moderna-shared cancer vaccine mRNA-4157. “We're undergoing a pretty substantial transformation from a…#keytruda #merckcos #moderna #mrna4157 #eliavbarr #mdmercks #fiercebiotech #merck #cmo #fda (Source: Reuters: Health)

Perioperative Chemo Extends Survival in Resectable Esophageal Cancer

MedPage Today Gastroenterology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- A perioperative regimen of four cycles of chemotherapy before and after surgery extended overall survival (OS) compared with neoadjuvant chemoradiation in patients with locally-advanced, resectable esophageal adenocarcinoma... (Source: MedPage Today Gastroenterology)

Geisel Medical Student Leads Skin Cancer Prevention Efforts

News at Dartmouth Medical School — Thu, 06 Jun 2024 21:17:47 +0100

Dartmouth recently earned national recognition as a Skin Smart Campus from the National Council on Skin Cancer Prevention, thanks to the efforts of Jamie Karch, who earned her MD degree from Geisel in May, and many collaborators across Dartmouth and the broader Upper Valley community. (Source: News at Dartmouth Medical School)

Breast cancer drug denied on NHS gives incurable women 'precious extra time'

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Research presented at the world's largest cancer conference has added fuel to the fire for campaigners demanding the NHS strikes a deal with manufacturers. (Source: Daily Express - Health)

Carl June compares his new CAR T-cell therapy to 'an armored truck or tank'

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

Dr. Carl June is seeking to take the cancer-fighting cell therapy he developed more than a dozen years ago at the University of Pennsylvania to the next level. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Message:

Understanding CAR T-cell therapy: A conversation with Northside ’s Dr. Melhem Solh

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

Dr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers common questions about CAR T-cell therapy and discusses its role in the treatment of cancer. What is CAR T-cell therapy and how does it work? Dr. Melhem Solh: CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an advanced form of cancer treatment that uses the body ’s own immune system to fight cancer cells. A patient’s own T-cells are engineered to find and destroy cancer cells.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

'I just want to watch my daughter grow up': Mother's heartbreaking plea for breast cancer wonder drug Enhurtu being denied to women on the NHS, as new data shows it boosts survival by more than a third

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

The latest trial results found Enhertu slashed the chances of terminal breast cancer growing or spreading by 38 per cent compared to standard chemotherapy. (Source: the Mail online | Health)

Lymphadenectomy Not Needed in Advanced Ovarian Cancer With Optimal Surgery

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Omitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy did not compromise outcomes and resulted in less... (Source: MedPage Today Hematology/Oncology)

Two wonder drugs that 'melt away' colon cancers in up to 100 PERCENT of patients could help halt epidemic in young people

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

An immunotherapy drug 'melted' away tumors in nearly six in 10 colorectal cancer patients without surgery, according to a study presented this weekend at the ASCO conference in Chicago. (Source: the Mail online | Health)

Does Palliative Care via Telehealth Work in Advanced Cancer? Does Palliative Care via Telehealth Work in Advanced Cancer?

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Early palliative care can be delivered successfully and efficiently using telehealth in patients with advanced lung cancer and could improve patient access to this evidence-based care.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

How to Cope With the Financial Toll of Cancer

TIME: Health — Thu, 06 Jun 2024 21:17:47 +0100

Cancer isn’t just emotionally and physically taxing: It can take a steep financial toll on patients, caregivers, and families. In fact, two years after a diagnosis, adults with cancer are 71% more likely to experience financial problems than those without a cancer diagnosis, according to January 2022 research in the Journal of Clinical Oncology. This type of financial hardship due to medical bills is sometimes referred to as financial toxicity, or when out-of-pocket medical costs not covered by health insurance cause money problems for a patient. [time-brightcove not-tgx=”true”] Cancer care costs vary widely by the type of disease and the stage at which it’s diagnosed. Insurance claims for an initial kidney cancer diagnosis average about $39,500 annually, ac...

A Bird’s Eye View of the Tumor Microenvironment

The Scientist — Thu, 06 Jun 2024 21:17:47 +0100

Immune cells form different communities throughout a tumor, potentially disrupting how cancers respond to treatments. (Source: The Scientist)

NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy

National Institutes of Health (NIH) News Releases — Thu, 06 Jun 2024 21:17:47 +0100

Tool uses routine clinical data to predict whether a cancer will respond to immune checkpoint inhibitors. (Source: National Institutes of Health (NIH) News Releases)

Horror warning as UK facing surge in cancer cases in under-50s due to common food

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Ultra-processed foods are a major factor contributing to cancer diagnosis rates among young people rising by a quarter in two decades. (Source: Daily Express - Health)

EmeritusDX Continues Expansion, Announces New Director of Sales for Central U.S.

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

This appointment reflects EmeritusDX's commitment to expanding its presence as a national provider of cancer diagnostic and information services. LAKE FOREST, Calif. , June 3, 2024 /PRNewswire-PRWeb/ -- EmeritusDX, a rapidly growing cancer diagnostics and information company, is pleased... (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message:

Unlocking precision medicine: An overview of Illumina's TSO500, Upcoming Webinar Hosted by Xtalks

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

In this free webinar, learn about comprehensive genomic profiling (CGP) and the application of next-generation sequencing in oncology clinical trial biomarker studies. Attendees will gain insights into TruSight Oncology 500 (TSO500), a kitted GCP assay and research-use only tool that... (Source: PRWeb: Medical Pharmaceuticals)

Healthcare use and costs in the last six months of life by level of care and cause of death - Michel YA, Aas E, Augestad LA, Burger E, Thoresen L, Bj ørnelv GMW.

SafetyLit — Thu, 06 Jun 2024 21:17:47 +0100

BACKGROUND: Existing knowledge on healthcare use and costs in the last months of life is often limited to one patient group (i.e., cancer patients) and one level of healthcare (i.e., secondary care). Consequently, decision-makers lack knowledge in order to... (Source: SafetyLit)

An mRNA Melanoma Vaccine Shows Promise

TIME: Health — Thu, 06 Jun 2024 21:17:47 +0100

Moderna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest results from its trial involving 157 people with advanced skin cancer at the annual meeting of the American Society of Clinical Oncology in Chicago. In the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint inhibitor pembrolizumab (Keytruda)—to achieve potentially life-changing results for melanoma patients. [time-brightcove not-tgx=”true”] In the phase 2 study of patients with stage 3 or stage 4 melanoma who were treated after surgery to remove the bulk of their tumors, two thirds received a monthly dose of Moderna’s can...

Gene-Targeted Immunotherapy Boosts Survival for Some Colon Cancer Patients

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

MONDAY, June 3, 2024 -- There's potential good news for a sizable minority of people battling advanced colon cancer.Doctors in Britain say that an immunotherapy drug, given before surgery, can help many more patients with a specific genetic profile... (Source: Drugs.com - Daily MedNews)

Lack of Insurance Keeps Many Americans From Best Cancer Meds

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

MONDAY, June 3, 2024 -- A cutting-edge class of drugs is saving and extending the lives of cancer patients.But the drugs, called immune checkpoint inhibitors (ICIs), are so expensive that some uninsured Americans can't access them, a new report... (Source: Drugs.com - Daily MedNews)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

UK ’s National Health Service Tests AI Tool That Can Spot Cancer in Mammograms Missed by Doctors

Dark Daily — Thu, 06 Jun 2024 21:17:47 +0100

This AI platform has the potential to also reduce workload of radiologists, but also of anatomic pathologists and oncologists allowing them to be more productive When the UK’s National Health Service (NHS) recently tested an artificial intelligence (AI) platform’s ability to analyze mammograms, the AI found early signs of breast cancer that “human doctors” had […] The post UK’s National Health Service Tests AI Tool That Can Spot Cancer in Mammograms Missed by Doctors appeared first on Dark Daily. (Source: Dark Daily)

Ultra-processed food and obesity could be behind 'disturbing' rise in cancer hitting young people, warn UK's top doctors

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

More young people than ever are getting cancer, with diagnosis rates rising by a quarter in two decades. (Source: the Mail online | Health)

Can MRI replace PSA test in prostate cancer screening?

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

MRI isn't yet ready to replace prostate-specific antigen (PSA) testing as a first-line screening exam for prostate cancer, researchers have reported. A team led by Roman Gulati of Fred Hutchinson Cancer Center in Seattle found that "despite the potential attractiveness of first-line imaging-based [prostate cancer] screening, [a] microsimulation model showed that first-line [biparametric MRI]-based screening substantially increased rates of false-positive test results, prostate biopsy, and overdiagnosis without proportionately substantial reductions in prostate cancer mortality compared with first-line PSA testing with reflex [multiparametric MRI]." The study findings were published June 3 in Annals of Internal Medicine. First-line prostate cancer screening is currently performed with PSA...

$30 too much a month keeps a cancer patient in Georgia from cheaper care

NPR Health and Science — Thu, 06 Jun 2024 21:17:47 +0100

(Source: NPR Health and Science)

How earning $30 too much a month keeps a cancer patient in Georgia from cheaper care

NPR Health and Science — Thu, 06 Jun 2024 21:17:47 +0100

(Source: NPR Health and Science)

MedWorm Message:

Princess Kate's opportunity for public appearance hotly debated

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Princess Kate's impending decision on whether to step out on the balcony of Buckingham Palace in London during her ongoing treatment for cancer has stirred significant debate in the U.K. media. Kensington Palace urged the media to avoid speculation in March when the Princess of Wales announced she…#buckinghampalace #kensingtonpalace #dailybeast #dailymail #windsorberkshire #vanityfair #dailymirror #mirror #gbnews #troopingcolour (Source: Reuters: Health)

GSK shares tumble by most in two years after Zantac ruling

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

GSK shares dropped by the most in nearly two years after a ruling by the Delaware State Court that will allow jury trials in cases brought by cancer sufferers who say the heartburn drug Zantac caused their condition.#gsk #delawarestatecourt (Source: Reuters: Health)

Mailed Outreach for CRC Screening Appeals to Younger Adults Mailed Outreach for CRC Screening Appeals to Younger Adults

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

In a comparison of four outreach approaches, sending an FIT kit via mail garnered better response rates than other opt-in strategies to screen people aged 45-49, regardless of race/ethnicity.MDedge News (Source: Medscape Hematology-Oncology Headlines)

GSK shares tumble after Delaware court ruling on Zantac

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Ruling means plaintiffs can present evidence alleging link between heartburn drug and cancer (Source: Reuters: Health)

Telix completes BLA submission for investigational PET agent

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Telix Pharmaceuticals has completed the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its new PET agent, TLX250-CDx. TLX250-CDx (Zircaix) characterizes renal masses as clear cell renal cell carcinoma, the company said. It initiated the BLA submission in December 2023, basing it on its phase III ZIRCON study, which showed the agent to have a sensitivity of 86%, a specificity of 87%, and a positive predictive value (PPV) of 93% for clear cell renal cell carcinoma. (Source: AuntMinnie.com Headlines)

Direct Access Colonoscopy Saves Time With Comparable Results Direct Access Colonoscopy Saves Time With Comparable Results

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Direct access colonoscopy was as effective as office-scheduled colonoscopy for completing screening or surveillance within 90 days of contacting the gastroenterology office.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Synthetic Systems for Studying Natural Cells

The Scientist — Thu, 06 Jun 2024 21:17:47 +0100

Oskar Staufer engineers synthetic systems to explore cancer biology. (Source: The Scientist)

Declines in smoking and the advent of screening and newer drugs have vastly improved the outlook for patients with lung cancer, once considered a death sentence

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

. (Source: Reuters: Health)

Improved Outcomes With Subcutaneous Amivantamab in NSCLC Improved Outcomes With Subcutaneous Amivantamab in NSCLC

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Subcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

MedWorm Message:

Triplet Notches Survival Win in Heavily Pretreated DLBCL

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- A triplet combination consisting of the antibody-drug conjugate brentuximab vedotin (BV; Adcetris) plus lenalidomide (Revlimid) and rituximab for diffuse large B-cell lymphoma (DLBCL) improved survival in the third... (Source: MedPage Today Hematology/Oncology)

8 innovations in neuroscience and brain research at Mayo Clinic

News from Mayo Clinic — Thu, 06 Jun 2024 21:17:47 +0100

Mayo Clinic researchers lead discoveries into many conditions, including cancer, Alzheimer's disease and other forms of dementia, as well as how the brain fundamentally works. (Source: News from Mayo Clinic)

Amplia Therapeutics Convenes Expert Oncology Board

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Amplia Therapeutics Ltd. (AU:ATX) has released an update. Amplia Therapeutics Ltd. has bolstered its pursuit of novel cancer treatments by appointi...#atx (Source: Reuters: Health)

Alphamab Oncology Reports Promising Trial Results

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Alphamab Oncology (HK:9966) has released an update. Alphamab Oncology has announced encouraging results from its phase I/II clinical trial, JSKN003... (Source: Reuters: Health)

Simcere ’s ENZESHU Shows Promise in Ovarian Cancer Trial

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

https://www.tipranks.com/news/company-announcements/simceres-enzeshu-shows-promise-in-ovarian-cancer-trial?utm_source=biztoc.com&utm_medium=referral (Source: Reuters: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Britain facing cancer timebomb in the under-50s due to poor diet and gut health - and ultra-processed food could be to blame

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

More young people than ever are getting cancer, with diagnosis rates rising by a quarter in two decades. (Source: the Mail online | Health)

AstraZeneca ’s Tagrisso greatly slows cancer for some people with stage 3 lung cancer

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

AstraZeneca’s Tagrisso greatly slows cancer for some people with stage 3 lung cancer In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%. “This…#astrazeneca #tagrisso #davidrspigel (Source: Reuters: Health)

Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- The antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved progression-free survival (PFS) versus chemotherapy in previously treated metastatic hormone receptor-positive (HR... (Source: MedPage Today Hematology/Oncology)

Novel CD40 Agonist-Chemo Combo Shows Promise in Pancreatic Cancer

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- The investigational CD40 agonist mitazalimab and modified FOLFIRINOX demonstrated encouraging activity in patients with previously untreated metastatic pancreatic ductal adenocarcinoma, according to the phase Ib... (Source: MedPage Today Hematology/Oncology)

Wonder drug could triple survival rates of deadly bowel cancer - as medicine that 'melts away' tumours is already available in NHS

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Doctors say the drug - could be a 'game-changer' for patients with this type of bowel cancer, affecting around 3,000 Britons each year. (Source: the Mail online | Health)

MedWorm Message:

'Disturbing' surge in young cancers may be linked to gut health, say experts

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Cancer rates have increased by more than twice as much among young adults compared with the over 75s since the 1990s. (Source: Daily Express - Health)

'Practice Changing' Trial for Inoperable Locally Advanced NSCLC

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Patients without disease progression following chemoradiotherapy for unresectable stage III non-small cell lung cancer (NSCLC) should receive osimertinib (Tagrisso) if they harbor EGFR mutations, experts said here... (Source: MedPage Today Hematology/Oncology)

Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Progression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf; Blenrep) combined with pomalidomide (Pomalyst) and dexamethasone (BPd), compared with standard-of-care pomalidomide, bortezomib... (Source: MedPage Today Hematology/Oncology)

Breakthrough bowel cancer drug 'could triple survival chances' for some patients

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Pembrolizumab is already available on the NHS to treat later stage bowel cancer and other cancers including breast, cervical and lung. (Source: Daily Express - Health)

Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Early palliative care delivered via video was as effective as in-person visits on quality-of-life (QoL) measures among patients with advanced lung cancer, according to the REACH-PC trial. Further, patient and caregiver... (Source: MedPage Today Hematology/Oncology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

The rise of theranostics: Part 3 -- What is a theranostics center?

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

This report summarizes the results of IMV Medical Information Division’s 2024 survey of U.S. hospitals and cardiology practices that perform nuclear medicine [NM] procedures using fixed SPECT/CT, SPECT, and planar-only cameras.) "My philosophy about a theranostics provider is somebody that takes total and comprehensive care of all of the aspects of the radiopharmaceutical therapy for a particular cancer," Siegel added. "For prostate cancer therapy for example, that might be six treatments over 36 weeks with the theranostics practitioner really taking responsibility for all aspects of the patient's care and then turning the patient back to the referring medical oncologist at the end of the therapy." That means collecting all the data, lab and genomic evaluation, previous therapy data...

High-Deductible Health Plans, Prior Auth Harm Cancer Care High-Deductible Health Plans, Prior Auth Harm Cancer Care

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

For patients with cancer, the increased financial burden of high-deductible health plans and delayed access to pain meds caused by prior authorization policies may harm patient well-being and survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Astra's Enhertu delays breast cancer in patients with low HER2 levels

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

(Source: Reuters: Health)

New blood test 'can predict' breast cancer return

BBC News | Health | UK Edition — Thu, 06 Jun 2024 21:17:47 +0100

The test can find traces of a tumour's DNA before a full relapse, allowing treatment to start early, experts say. (Source: BBC News | Health | UK Edition)

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. SEER, a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to date…#seerinc #seer #prognomiq #seerproteographsp100 #xt #stac #redwoodcity #brucewilcox #pacifictime #thermofisher (Source: Reuters: Health)

MedWorm Message:

Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway …

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

HER2 status was accurately assessed in 172 patients with advanced breast, gastroesophageal, and ovarian cancers • ER status was accurately assessed and the level of ER pathway activation quantified in 87 patients with advanced breast cancer • Results support the relevance of the Precede Bio…#precedebio #boston #precedebiosciences #mccormickplace #illinois #carlbarrett #asco #stefaniamorganti #annualmeeting (Source: Reuters: Health)

Cancer patients often do better with less intensive treatment, new research finds

ABC News: Health — Thu, 06 Jun 2024 21:17:47 +0100

Scaling back treatment for some cancers can make life easier for patients without hurting the outcomes (Source: ABC News: Health)

Drug that ‘melts away’ tumours could replace surgery for bowel cancer, say doctors

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

All patients in pembrolizumab trial were found to be cancer-free after combination of drug and surgeryA “gamechanger” immunotherapy drug that “melts away” tumours dramatically increases the chances of curing bowel cancer and may even replace the need for surgery, doctors have said.Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells.Continue reading... (Source: Guardian Unlimited Science)

GSK blood cancer drug nearly halves risk of death in late-stage trial

The Economic Times Healthcare and Biotech News — Thu, 06 Jun 2024 21:17:47 +0100

In the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with the steroid dexamethasone and pomalidomide were alive without their disease worsening at the end of a year. That compared with progression-free survival (PFS) of 51% of those who were treated with pomalidomide, dexamethasone and bortezomib. Pomalidomide is a generic version of Bristol Myers Squibb's Pomalyst, while bortezomib is the generic of Takeda Pharmaceuticals' Velcade. (Source: The Economic Times Healthcare and Biotech News)

Have you got VAPE FACE? Amid claims that Gen Z look older than they should, a top dermatologist reveals how vaping can age the skin by decades

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

It's not just cigarettes, vaping is responsible for causing wrinkly skin, breakouts and cancers on the lip, says London based dermatologist Dr Bav Shergill. (Source: the Mail online | Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

ASCO: Jazz shares'unprecedented' biliary tract cancer data

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

As zanidatamab awaits an FDA approval decision, Jazz Pharmaceuticals is sharing long-term phase 2b data in advanced biliary tract cancer (BTC) for the HER2-targeted bispecific antibody. The data set includes the first overall survival (OS) findings from the study, with zanidatamab demonstrating a…#fda #jazzpharmaceuticals #robiannone #fiercebiotech #roche #median #ihc #jazz #zymeworks (Source: Reuters: Health)

'I'm a doctor - this incredible diet can slash risk of diabetes, dementia and even cancer'

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

This diet does not dictate your calorie intake or portion size. (Source: Daily Express - Health)

‘The Life and Murder of Nicole Brown Simpson’ Bosses on 10-Year Journey to the Docuseries

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Though Lifetime first announced the four-part docuseries, The Life and Murder of Nicole Brown Simpson, on April 12 — one day after O.J. Simpson died from metastatic prostate cancer at the age of 76 — the project has actually been a decade coming, says one of its executive producers, Melissa Moore.…#ojsimpson #melissamoore #hollywoodreporter #denisebrown #dominique #tanya #briemirandabryant #jessedaniels #survivingrkelly #nicole (Source: Reuters: Health)

Weight-loss jabs like Wegovy and Ozempic reduce risk of some of the most common and deadly cancers, study suggests

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

After smoking, obesity is thought to be the second most common cause of cancer in the UK and is responsible for around one in 20 new cases every year. (Source: the Mail online | Health)

Doctors hail blood test that predicts if breast cancer will come back years before it shows up on scans

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Doctors say it could have a 'transformative effect' on outcomes for breast cancer, saving many of the 11,500 lives a year lost in the UK to the disease. (Source: the Mail online | Health)

MedWorm Message:

Gamechanging blood test predicts breast cancer relapse up to three years before scans

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

The breakthrough could allow women to start treatment before the disease becomes incurable. (Source: Daily Express - Health)

Calls to test for gene cause of breast cancer that hit BBC's Victoria Derbyshire and Angelina Jolie

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

A new study suggests some cases are hereditary and caused by a faulty gene, meaning tests could have the potential to identify women at risk of the disease, even before the cancer starts to grow. (Source: the Mail online | Health)

Predictive blood test hailed as ‘incredibly exciting’ breast cancer breakthrough

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

New ‘liquid biopsy’ will act as an early warning sign to anticipate risk of tumours returningA new blood test can predict the risk of breast cancer returning three years before any tumours show up on scans in an “incredibly exciting” breakthrough that could help more women beat the disease for good.More than 2 million women are diagnosed every year with breast cancer, the most prevalent type of the disease. Although treatment has improved in recent decades, the cancer often returns, and if it does, it is usually at a more advanced stage.Continue reading... (Source: Guardian Unlimited Science)

' Outstanding' 5 Year PFS With Lorlatinib in ALK+ NSCLC'Outstanding' 5 Year PFS With Lorlatinib in ALK+ NSCLC

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Five-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some experts question the use of crizotinib as the comparator drug.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Subcutaneous amivantamab (Rybrevant) was non-inferior to IV amivantamab for pre-treated patients with refractory EGFR-mutated, advanced non-small cell lung cancer (NSCLC), with the suggestion of a possible survival... (Source: MedPage Today Hematology/Oncology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

' Impressive' 5-Year PFS With Lorlatinib in ALK+ NSCLC'Impressive' 5-Year PFS With Lorlatinib in ALK+ NSCLC

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Pfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the strength of data presented on Friday showing most patients treated for a rare form of advanced lung cancer in a clinical trial were alive without the disease worsening after five years. Lorbrena, like…#pfizer #xalkori #alk #lorbrena #crown #chrisboshoff #nsclc (Source: Reuters: Health)

Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- An investigational bispecific antibody targeting PD-1 and VEGF significantly decreased the risk of disease progression or death in patients with metastatic EGFR-mutant non-small cell lung cancer (NSCLC) who progressed... (Source: MedPage Today Hematology/Oncology)

ASCO: In surprise, J & J's injectable Rybrevant extends lung cancer patients' lives versus intravenous version

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

When companies introduce an injectable version of an intravenously infused drug, better convenience with comparable efficacy is typically the goal. But to Johnson & Johnson’s surprise, a subcutaneous (SC) formulation of its lung cancer med Rybrevant proved to work better than the original…#johnsonjohnsons #yuhan #nsclc #iv #scrybrevants #scrybrevant #astrazeneca #fda #fiercepharma #egfr (Source: Reuters: Health)

Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Replacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced classical Hodgkin lymphoma (cHL) with no loss in efficacy, according to a randomized study reported. The estimated 4... (Source: MedPage Today Hematology/Oncology)

MedWorm Message:

Top doctors warn against $1,000 blood tests that claim to detect 50 types of cancer - urging Americans not to skip critical screenings

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Top doctors at the FDA and the American Cancer Society warned against multi-cancer detection tests at the American Society for Clinical Oncology conference in Chicago this weekend. (Source: the Mail online | Health)

GSK set to face jury trials over heartburn drug Zantac

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Judge rules experts’ evidence admissible, leaving route open for 72,000 cancer sufferers to bring cases (Source: Reuters: Health)

SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients …

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for efficacy • SYS6002 (CRB-701) demonstrated 44% ORR and 78% DCR in mUC and 43% ORR and 86% DCR in cervical cancer to date at doses ≥ 1.2mg/Kg • No dose limiting toxicities (DLTs)…#sys6002 #dcr # #norwood #mass #corbus #jianzhang #chiefphysician #phase1centre #cspc (Source: Reuters: Health)

Bristol ’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

(Source: Reuters: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

At-home saliva test may catch deadly prostate cancers

BBC News | Health | UK Edition — Thu, 06 Jun 2024 21:17:47 +0100

Research suggests cheap and simple spit tests may be better at catching the disease than blood tests. (Source: BBC News | Health | UK Edition)

Huge breakthrough as simple at-home saliva test could ‘turn tide’ on prostate cancer

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

The saliva test searches for markers in patients' DNA to determine their genetic risk of developing prostate cancer. (Source: Daily Express - Health)

Men's Health Month: Insights, treatments and transformative outcomes for prostate health

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

June is Men ’s Health Month. One of the most common health complications that men face is benign prostatic hyperplasia (BPH), which is commonly known as an enlarged prostate. BPH is a non-cancerous enlargement of the prostate gland, and if left untreated it can lead to significant health challenges for men. There are a lot of treatments out there, ranging from medications to minimally invasive surgeries. However, one of the biggest challenges can be overcoming the stigma associated with seeking… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Pfizer's LORBRENA ® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

(Source: Reuters: Health)

People's last words are often these 4 phrases: What they teach us about living happy, meaningful lives, from an oncologist

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Everyone's life is different — yet most people still utter one of four common phrases on their deathbeds, according to Pulitzer Prize-winning author and oncologist Siddhartha Mukherjee. Each of the phrases offers an important lesson for leading a fulfilling and successful life, Mukherjee said…#pulitzerprize #siddharthamukherjee #jkimpenberthy #richardcowden #learn #cowden #harvardmedicalschool #earlybird (Source: Reuters: Health)

MedWorm Message:

Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

On Friday, Summit Therapeutics Inc (NASDAQ:SMMT) shares are trading lower after the company’s stock closed 272.1% higher at $10.92 on Thursday. Thursday, Summit Therapeutics Inc (NASDAQ:SMMT) announced that Phase 3 HARMONi-2, or AK112-303, met its primary endpoint of progression-free survival…#ak112303 #nsclc #phase3 #akesoinc #akeso #bicr #merckcoincs #benzingaproclick #multibillionkeytruda #chinastudy (Source: Reuters: Health)

Simple DIY saliva test that could help pick up prostate cancer before symptoms strike - and experts say kits could even be sent in the post

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

The cheap test - which looks for genetic markers of the cancer in people's DNA - was more effective than the current blood test men can request from their GP. (Source: the Mail online | Health)

Scientists develop cheap and quick spit test for prostate cancer

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

DNA test, which takes seconds to collect, can detect men at high risk and spare others unnecessary treatmentScientists have developed a spit test that could “turn the tide” on prostate cancer worldwide by spotting the disease earlier, detecting where men are at high risk and sparing others unnecessary treatment.The number of men diagnosed with prostate cancer worldwide is projected to double to2.9 million a year by 2040, with annual deaths predicted to rise by 85%. It is already the most common form of male cancer in more than 100 countries.Continue reading... (Source: Guardian Unlimited Science)

Gilead drug fails to confirm its FDA approval in bladder cancer

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

The drug is approved for breast cancer, but the FDA could remove its approval in bladder cancer. It failed a late-stage trial earlier this year in a type of lung cancer. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- While suicide rates continue to rise nationwide, the rate among patients with cancer has been declining. (Translational Psychiatry) Patient-centered care is the focus of an update to an American Society for Radiation Oncology... (Source: MedPage Today Hematology/Oncology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Active Surveillance Effective Strategy for Favorable-Risk Prostate Cancer

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

FRIDAY, May 31, 2024 -- Active surveillance is an effective management strategy for men with favorable-risk prostate cancer, with an estimated rate of metastasis of 1.4 percent at 10 years after diagnosis, according to a study published online May... (Source: Drugs.com - Pharma News)

Key Endoscopy Studies That Could Transform Your Practice Key Endoscopy Studies That Could Transform Your Practice

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Dr David Johnson provides insight on 11 studies from this year's Digestive Disease Week, including pivotal research on endoscopy as well as new data on phase 3 drugs and colorectal cancer screening.Medscape Gastroenterology (Source: Medscape Hematology-Oncology Headlines)

EMA Panel Nods to Seven New Cancer Drugs EMA Panel Nods to Seven New Cancer Drugs

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The drugs include an anti –PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Critics slam Canadian breast screening guidelines

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Breast imaging organizations and political bodies are criticizing updated guidelines on breast cancer screening by the Canadian Task Force on Preventive Health Care (CTFPHC). Released on May 30, the task force’s draft guidelines recommend that women between the ages of 40 and 49 should not be systematically screened. Instead, these women are advised to have informed conversations with their primary care provider and make their own screening decisions from there. Additionally, the guidelines do not recommend supplemental imaging in women with dense breasts or women with a personal family history of breast cancer. “There’s so much misinformation out there, so we want women to be able to advocate for the screening they need, to know that breast cancer can happen at any age,” said Je...

EMA Authorizes Hemophilia B Gene Therapy EMA Authorizes Hemophilia B Gene Therapy

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The European Medicines Agency has given the go-ahead for Durveqtix to treat hemophilia B in adults and to Adzynma for patients with congenital thrombotic thrombocytopenic purpura.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

MedWorm Message:

This well-timed ‘chameleon’ sneaks up on drug-resistant brain cancers

Yale Science and Health News — Thu, 06 Jun 2024 21:17:47 +0100

Yale scientists say KL-50, their lead “chameleon” compound, effectively targets tumors without harming healthy surrounding tissue. (Source: Yale Science and Health News)

Washington Research Foundation awards more than $2 million in grants to support the development of plans for life-science initiatives in the state

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

Investigators at Fred Hutch Cancer Center, the Seattle Hub for Synthetic Biology, the University of Washington and Washington State University will use funding to develop plans for large-scale efforts that can significantly enhance the life-science innovation ecosystem in Washington state... (Source: PRWeb: Medical Pharmaceuticals)

How your sexual preference can raise your chance of multiple CANCERS, according to first-of-its-kind report

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

A first-of-its-kind report from the American Cancer Society found that lesbian, gay, bisexual and transgender individuals are more likely to smoke, drink alcohol and be obese, raising cancer risk. (Source: the Mail online | Health)

Pfizer drug extends life for people with rare form of lung cancer

The Economic Times Healthcare and Biotech News — Thu, 06 Jun 2024 21:17:47 +0100

A Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival outcomes for people in the advanced stages of a rare form of the disease, according to trial results published Friday. (Source: The Economic Times Healthcare and Biotech News)

HPV Testing Outperforms Pap Smear for Detecting Cervical Cancer Precursor Lesions

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- The risk of developing cervical neoplasia 8 years after human papillomavirus (HPV) testing was similar to 3 years after a negative Pap test, a large longitudinal cohort study showed. Patients with one or two negative HPV tests... (Source: MedPage Today Hematology/Oncology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

New lung cancer pill hailed as 'off the charts' success - with patients surviving years longer than those on next best treatment

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Around six in ten patients given the daily tablet treated with lorlatinib survived for five years without their cancer progressing, compared to just eight per cent receiving standard care. (Source: the Mail online | Health)

Doctor hails launch of personalised cancer vaccine as a 'new age' in fight against disease

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

EXCLUSIVE: The jab could "save thousands of lives", a top doctor has said. (Source: Daily Express - Health)

Scott Asner of Eighteen Capital Group Celebrates Cancer Survivors on National Cancer Survivors Day

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

Scott Asner, Founding Principal of Eighteen Capital Group in Leawood, Kansas, honors those who have faced off and survived cancer on National Cancer Survivors Day. LEAWOOD, Kan., May 31, 2024 /PRNewswire-PRWeb/ -- Scott Asner, Founding Principal of Eighteen Capital Group (18CG), a... (Source: PRWeb: Medical Pharmaceuticals)

STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CML

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- The STAMP inhibitor asciminib (Scemblix) had a statistically superior response rate compared with investigator-selected tyrosine kinase inhibitors (TKIs) for patients with newly diagnosed chronic myeloid leukemia... (Source: MedPage Today Hematology/Oncology)

'A major step forward': New lung cancer pill hailed as 'off the charts' success - with patients surviving seven times longer than those on next best treatment

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

MedWorm Message:

Lung cancer wonder drug hailed as study shows 'off the chart' survival benefit

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

Results from a trial of daily pill lorlatinib were described as "unprecedented". (Source: Daily Express - Health)

Trial results for new lung cancer drug are ‘off the charts’, say doctors

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

More than half of patients with advanced forms of disease who took lorlatinib were still alive after five years with no progressionDoctors are hailing “off the chart” trial results that show a new drug stopped lung cancer advancing for longer than any other treatment in medical history.Lung cancer is the world ’s leading cause of cancer death, accounting for about 1.8m deaths every year. Survival rates in those with advanced forms of the disease, where tumours have spread, are particularly poor.Continue reading... (Source: Guardian Unlimited Science)

Unprecedented PFS Results in ALK-Positive Lung Cancer Trial

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- CHICAGO -- Five-year results from a phase III trial had experts gushing over lorlatinib's (Lorbrena) progression-free survival (PFS) benefit in ALK-positive non-small cell lung cancer (NSCLC). In the first-line CROWN trial... (Source: MedPage Today Hematology/Oncology)

Bariatric Surgery May Reduce Breast Cancer Risk for Some Bariatric Surgery May Reduce Breast Cancer Risk for Some

Medscape Diabetes Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Bariatric surgery was associated with a lower risk for breast cancer in women with obesity who had higher baseline insulin levels or who were premenopausal, new data suggested.Medscape Medical News (Source: Medscape Diabetes Headlines)

All your questions answered on the cancer vaccine revolution: how they work, how likely you are to get one... and how they're made in the same way as the Covid jabs

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Doctors believe the treatments - which are custom built for each patient - will herald a new era in cancer care, here MailOnline answers all your questions on the breakthrough jabs. (Source: the Mail online | Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Why does King Charles have two birthdays? Trooping the Colour explained

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Buckingham Palace announced this week that King Charles III will take part in the annual Trooping the Colour celebrations in June despite still receiving treatment for an undisclosed form of cancer. The monarch has had the green light from his medical team to resume his public-facing duties,…#buckinghampalace #kingcharlesiii #troopingthe #colour #troopingcolour #kingcharles #charlesiii #georgeii #georgeiii #whatistroopingcolour (Source: Reuters: Health)

Does Diet Affect Progression Risk After Prostate Cancer? Does Diet Affect Progression Risk After Prostate Cancer?

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

A Mediterranean diet of vegetables and fruits, olive oil, fish, and small amounts of red meat is beneficial for patients with cancer, data suggested.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Stress, Discrimination Add to Cancer Burden for LGBTQ+ Americans

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

FRIDAY, May 31, 2024 -- While LGBTQ+ people have higher risk factors for cancer, they are apt to face discrimination when in need of high-quality medical care, a new report shows. In particular, LGBTQ+ people have to worry that a health care... (Source: Drugs.com - Daily MedNews)

ConcertAI expands multimodal data, RWD management

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

ConcertAI will spotlight its new and expanded multimodal and real-world data management offerings with Cara AI and the TeraRecon Oncology Suite at the American Society of Clinical Oncology (ASCO)'s annual meeting this week. Both products are designed to enhance research capabilities and support complex clinical study workflows, according to ConcertAI.Cara AI can combine radiological imaging studies, digital pathology, and structured and unstructured real-world data (RWD). The system also provides an open AI framework that enables scientists to embed and orchestrate AI algorithms (third party, first party, or open source) for retrospective and prospective image and data processing. ConcertAI also noted Cara AI includes:Advanced AI orchestrations across large language models (LLMs), natural ...

HPV Vaccine Offers Cancer Protection Beyond Cervical Cancer HPV Vaccine Offers Cancer Protection Beyond Cervical Cancer

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

HPV vaccination protects not only against cervical cancer in women but also other HPV-related cancers in men and women, most notably head and neck cancer in men, new data showed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

MedWorm Message:

Pfizer & #039;s LORBRENA ® CROWN study shows majority of patients with ALK-positive advanced lung cancer living beyond five years without disease progression

World Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from the Phase 3 CROWN trial evaluating LORBRENA® (lorlatinib, a third-generation ALK inhibitor, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). (Source: World Pharma News)

Frequent Cannabis Use Increases Risk for Lung Diseases Frequent Cannabis Use Increases Risk for Lung Diseases

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Research presented at the 2024 SGIM meeting suggested daily cannabis use may heighten asthma and COPD risks.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

LGBTQ+ individuals show decreased breast cancer screening rates

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Lesbian, gay, bisexual, transgender, queer, intersex, or gender‐nonconforming (LGBTQ+) individuals show decreased breast cancer screening rates, according to research published May 31 in Cancer. A team led by Tyler Kratzer of the American Cancer Society (ACS) in Atlanta reported that bisexual women have a breast cancer screening prevalence of 81%, non-binary individuals a prevalence of 76%, and transgender men a prevalence of 65%. The findings may be due to a number of factors, including fear that a provider will "refuse care due to gender identity or sexual orientation," "minority stress," fewer childbirths, and higher prevalence of alcohol use, Kratzer and colleagues noted. "Breast cancer outcomes are affected by access to high‐quality screening and treatment," they wrote. "One re...

Pandemic Had Temporary Negative Effect on Breast Cancer Screening

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

THURSDAY, May 30, 2024 -- The COVID-19 pandemic had a transient negative effect on breast cancer screening overall and a prolonged negative effect on follow-up screening, according to a study published in the May/June issue of the Annals of Family... (Source: Drugs.com - Pharma News)

Thousands to get cutting-edge personalised cancer vaccines in NHS trials

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

The latest vaccine technology is being used to create personalised treatments that target the DNA of patients' specific tumours. (Source: Daily Express - Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Summit Therapeutics ’ stock soars as biotech says its cancer drug beat Keytruda in Phase 3

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Hours before America’s biggest cancer conference starts in Chicago, a small biotech may have stolen the show, touting late-stage results in a Thursday afternoon press release that added over $5 billion to its market capitalization — with one major caveat. Summit Therapeutics said its experimental…#summittherapeutics #merck (Source: Reuters: Health)

Imagion Biosystems: Innovating Cancer Diagnostics

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Imagion Biosystems Ltd. (AU:IBX) has released an update. Imagion Biosystems Ltd. is revolutionizing cancer diagnosis with their latest investor pre...#imagionbiosystemsltd (Source: Reuters: Health)

Imagion Biosystems Navigates Financial Struggles

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Imagion Biosystems Ltd. (AU:IBX) has released an update. Imagion Biosystems Ltd., specialists in cancer detection imaging technology, presented an ...#imagionbiosystemsltd (Source: Reuters: Health)

Valar Labs, which has developed AI models to help predict bladder cancer treatment outcomes, raised a $22M Series A led by DCVC and a16z

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Putting AI to work in the healthcare industry is a tricky business; it’s even more so in oncology, where the stakes are especially high. Biotech startup Valar Labs is aiming high but starting small with a tool that accurately predicts certain treatment outcomes, potentially saving precious time…#biotech #valarlabs #bladder #valar #bcg #anirudhjoshi #stanford #vesta #cto #visweshkrishna (Source: Reuters: Health)

Summit Therapeutics sees stock soar 272% after lung cancer clinical trial

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

The duo of Bob Duggan and Maky Zanganeh also guided Sunnyvale's Pharmacyclics to success with the blood cancer drug Imbruvica and, ultimately, a $21 billion buyout. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Message:

In case you missed it: This week's Top 5 stories on social media

News from Mayo Clinic — Thu, 06 Jun 2024 21:17:47 +0100

Check out a few of the most popular News Network stories on @mayoclinic social media this past week. Mayo Clinic Minute: New chemotherapy approach for treating stomach cancer A new approach to treating stomach cancers called hyperthermic intraperitoneal chemotherapy (HIPEC) delivers heated liquid chemotherapy directly to the abdomen where it can target the cancer. Dr. Travis Grotz, a Mayo Clinic surgical oncologist, discusses how HIPEC works and the potential benefits of the treatment. Mayo Clinic… (Source: News from Mayo Clinic)

Mayo Clinic names new Department of Neurosurgery chair in Rochester

Mayo Clinic Business News — Thu, 06 Jun 2024 21:17:47 +0100

ROCHESTER, Minn. — Gelareh Zadeh, M.D., Ph.D., has been named the new Mayo Clinic Department of Neurosurgery chair in Rochester, beginning in the fall of 2024. Dr. Zadeh joins Mayo Clinic from the University of Toronto, where she is the University of Health Network's division head of Neurosurgery, the medical dire ctor of the Krembil Neuroscience Program, the co-director of the Krembil Brain Institute, a senior scientist at the Princess Margaret Cancer Centre, and the Dan… (Source: Mayo Clinic Business News)

Thousands of cancer patients to trial personalised vaccines

BBC News | Health | UK Edition — Thu, 06 Jun 2024 21:17:47 +0100

Thousands of people in England are set to get access to a new type of treatment to fight their disease. (Source: BBC News | Health | UK Edition)

Cancer patients start getting tailored vaccines on the NHS: Father-of-four becomes the first to receive a personalised vaccine while health chief hails 'landmark moment' as thousands to receive jabs

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Elliot Pfebve (pictured) became the first patient to receive a bowel cancer vaccine on the NHS, getting his first dose at University Hospitals Birmingham in March. (Source: the Mail online | Health)

What are cancer vaccines and have scientists finally found a cure?

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

The NHS in England is recruiting for the first large-scale trial of its kind, with hopes high that the personalised jabs could be a gamechangerNHS patients in England to be offered trials for world-first cancer vaccineCancer vaccines are a form of immunotherapy. Unlike vaccines that protect from an infection, such as the Covid-19 jab, cancer vaccines treat people who already have the disease. They are designed to help the patient ’s immune system recognise and then kill cancer cells – and prevent them from coming back.Continue reading... (Source: Guardian Unlimited Science)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

NHS patients in England to be offered trials for world-first cancer vaccine

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

Jab personalised for individual ’s tumours hailed as ‘gamechanger’ amid high hopes of stopping disease returningWhat are cancer vaccines and could they be a cure?Thousands of patients in England are to be fast-tracked into groundbreaking trials of personalised cancer vaccines in a revolutionary world-first NHS “matchmaking” scheme to save lives.The gamechanging jabs, which aim to provide a permanent cure, are custom-built for each patient in just a few weeks. They are tailored to the individual ’s tumours and work by telling their body to hunt and kill any cancer cells and prevent the disease from coming back.Continue reading... (Source: Guardian Unlimited Science)

Stanford Medicine Study Reveals Gene Variants Predict Future Breast Cancer Biology

Disabled World — Thu, 06 Jun 2024 21:17:47 +0100

Gene variants foretell the biology of future breast cancers in a Stanford Medicine study (Source: Disabled World)

Gilead's Trodelvy Fails to Meet Main Goal in Late-stage Cancer Study Gilead's Trodelvy Fails to Meet Main Goal in Late-stage Cancer Study

Medscape Medical News Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Gilead Sciences said on Thursday its drug Trodelvy, tested in patients with bladder cancer who previously received chemotherapy and other anti-cancer therapies, did not meet...Reuters Health Information (Source: Medscape Medical News Headlines)

Invitation: Roche ’s Virtual Hematology Investor Event

Roche Investor Update — Thu, 06 Jun 2024 21:17:47 +0100

We are pleased to invite investors and analysts to participate in our virtual event on Sunday, 16 June 2024, to highlight Ph III STARGLO results in 2L+ DLBCL presented during the EHA congress and provide an update in non-malignant hematology. 13:00 – 14:00 CEST / 12:00 – 13:00BST07:00 – 08:00 am EDT / 04:00 – 05:00 am PDT The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 12:00 CEST on the day of the event.>click here Access to virtual event (pre-registration required)Please pre-register for our webinarhere*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail toinvestor.relations@roche.com. A replay of the webcast will be av...

I was diagnosed with Stage 4 skin cancer at 22 despite having no visible moles or marks and never tanning

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

A young woman from Idaho was diagnosed with advanced skin cancer despite having no moles. Only 22 percent of people survive the disease after about five years. (Source: the Mail online | Health)

MedWorm Message:

URI nurse-educator wins $450K Betty Moore fellowship

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

Erica Leibermann is developing a model to improve cervical cancer outcomes. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Dying father-of-four, 37, who claimed he was 'fobbed off' by NHS doctors is given weeks to live after medics failed to spot he had cancer for 18 months

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Joe Snape, 37, (right) from Leek, Staffordshire, was told he had incurable oesophageal cancer in March despite first visiting his GP practice with stomach pains last year. (Source: the Mail online | Health)

G1 Therapeutics seeks partner to advance cancer treatment

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

G1 Therapeutics is looking to advance one of its cancer treatments to a critical phase 3 study. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

More Evidence Backs Active Surveillance for Low-Risk Prostate Cancer

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- Half of men with low-risk prostate cancer remained free from progression or treatment 10 years after diagnosis when followed in a protocol-directed active surveillance program. At 10 years, 43% of more than 2,000 patients had... (Source: MedPage Today Hematology/Oncology)

' Underwater' Repayment for Insurance-Preferred Biosimilars'Underwater' Repayment for Insurance-Preferred Biosimilars

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Dr Madelaine A. Feldman explains how the current situation of negative reimbursement for office-based infusion of certain biosimilars shows why change to the formulary construction system is needed.MDedge (Source: Medscape Hematology-Oncology Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Lymphoma Research Foundation Rebrands to Reflect Its Unifying Role Within the Lymphoma Community

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

Brand and visual identity demonstrate the Foundation's determination to support groundbreaking cancer research and commitment to improving the lives of the entire lymphoma community NEW YORK, May 30, 2024 /PRNewswire-PRWeb/ -- Today, the Lymphoma Research Foundation announced a brand... (Source: PRWeb: Medical Pharmaceuticals)

Nurse Fired After Referring to Gaza ‘ Genocide ’ in Speech for Award

TIME: Health — Thu, 06 Jun 2024 21:17:47 +0100

New York — A nurse was fired by a New York City hospital after she referred to Israel’s war in Gaza as a “genocide” during a speech accepting an award. Labor and delivery nurse Hesen Jabr, who is Palestinian American, was being honored by NYU Langone Health for her compassion in caring for mothers who had lost babies when she drew a link between her work and the suffering of mothers in Gaza. [time-brightcove not-tgx=”true”] “It pains me to see the women from my country going through unimaginable losses themselves during the current genocide in Gaza,” Jabr said, according to a video of the May 7 speech that she posted on social media. “This award is deeply personal to me for those reasons.” Jabr wrote on Instagram th...

Updated Canadian breast cancer guidelines recommend biennial screening

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Canadian women at average breast cancer risk should undergo biennial or triennial screening and make decisions based on individual values, according to new guidelines set by the Canadian Task Force on Preventive Health Care (CTFPHC). The task force on May 30 released its updated guidance on breast cancer screening, which recommends that women between the ages of 40 to 49 not be systematically screened for the disease with mammography but rather make their screening decisions based on informed discussions with their primary care provider. The guidelines differ slightly from the the recent U.S. Preventive Services Task Force (USPSTF) breast cancer screening guidelines, which recommended biennial screening, and do not support supplemental screening in women with dense breasts or with a fa...

FDA Prioritizes Keytruda Chemotherapy Mesothelioma Combo

Asbestos and Mesothelioma News — Thu, 06 Jun 2024 21:17:47 +0100

In a significant development for mesothelioma patients, the U.S. Food and Drug Administration has accepted priority review for a new supplemental Biologics License Application. The anticipated FDA approval could mark the beginning of a new era in the management of advanced pleural mesothelioma, offering a brighter future for those affected. The review seeks approval for the combination of Keytruda (pembrolizumab) with chemotherapy. As a frontline treatment, the combination of Merck’s anti-PD-1 therapy with chemo could benefit patients with mesothelioma that can’t be removed with surgery (unresectable) or metastatic malignant pleural mesothelioma. Dr. Gregory Lubiniecki, vice president of oncology clinical research at Merck Research Laboratories, emphasized the importance of this ...

The Experts on Lower Extremity Edema? Primary Care The Experts on Lower Extremity Edema? Primary Care

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

With a multitude of causes, you need a systematic approach to the differential of lower extremity edema.The Curbsiders (Source: Medscape Hematology-Oncology Headlines)

MedWorm Message:

US FDA Expands Use Of Bristol's Cell Therapy to Treat Rare Blood Cancer US FDA Expands Use Of Bristol's Cell Therapy to Treat Rare Blood Cancer

Medscape Internal Medicine Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Bristol Myers Squibb said on Thursday the U.S. FDA had allowed expanded use of its cell therapy for an aggressive and rare type of blood cancer, making it the third approval...Reuters Health Information (Source: Medscape Internal Medicine Headlines)

Optimal Management of Leptomeningeal Disease in MBC Optimal Management of Leptomeningeal Disease in MBC

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Fatima Cardoso, Priscilla Brastianos, Laura Huppert, Orit Kaidar-Person, and Volkmar M üller discuss the challenges of treating leptomeningeal disease as they strive to optimize patient care in MBC.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)

Recommendations Issued for Palliative RT for Symptomatic Bone Mets

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology, evidence-based recommendations are presented for the use of palliative... (Source: Drugs.com - Pharma News)

Scientists have discovered a 50,000-year-old herpes virus – and perhaps how modern humans came to rule the world | Jonathan Kennedy

Guardian Unlimited Science — Thu, 06 Jun 2024 21:17:47 +0100

Revolutionary ancient DNA evidence indicates that Homo sapiens finished off Neanderthals through deadly infectious diseasesLess than a decade ago, the American anthropologist James C Scott described infectious diseases as the “loudest silence” in the prehistoric archaeological record. Epidemics must have devastated human societies in the distant past and changed the course of history, but, Scott lamented, the artefacts left behind reveal nothing about them.Over the last few years, the silence has been shattered by pioneering research that analyses microbial DNA extracted from very old human skeletons. The latest example of this is agroundbreaking study that identified three viruses in 50,000-year-old Neanderthal bones. These pathogens still afflict modern humans: adenovirus, herpesviru...

Study Confirms Effectiveness of'Watch-and-Wait' Approach to Prostate Cancer

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

THURSDAY, May 30, 2024 -- For a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors advise a " watch-and-wait " approach instead of active treatment.Now, a study of almost 2,200 patients followed for up to a... (Source: Drugs.com - Daily MedNews)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Secondhand Smoke Increases Cisplatin Resistance in HNC Secondhand Smoke Increases Cisplatin Resistance in HNC

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Dr Maurie Markman discusses results from a study suggesting that secondhand smoke exposure may decrease the effectiveness of cancer treatment.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)

Most Women Can Conceive After Breast Cancer Treatment Most Women Can Conceive After Breast Cancer Treatment

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

New research suggested that most young women with nonmetastatic breast cancer can successfully conceive after treatment.MDedge News (Source: Medscape Hematology-Oncology Headlines)

NHSE will not extend high-profile cancer test pilot

HSJ — Thu, 06 Jun 2024 21:17:47 +0100

NHS England has decided not to extend the ongoing pilot of a high-profile emerging cancer screening technology, casting further doubt on its target to improve early detection. (Source: HSJ)

Using Prognostic AI Models in Pathology: Case Colorectal Cancer, Upcoming Webinar Hosted by Xtalks

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

In this free webinar, learn about the current state of colorectal pathology and pathologic features that guide oncologic decision-making. Gain insights into improving risk assessments for cancer patients with an AI-integrated scheme and digital pathology. The featured speakers will... (Source: PRWeb: Medical Pharmaceuticals)

Carefully Designing De-escalation Trials in Breast Cancer Carefully Designing De-escalation Trials in Breast Cancer

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

De-escalation trials in early breast cancer are " critical to preserving quality of life " but require careful planning.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

MedWorm Message:

The doctors' guide to knowing if your runny nose is silent reflux - and why a diagnosis is so important to stave off cancer

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Sam Cansfield was sat at her desk sipping coffee when she suddenly felt a crushing pressure build in her chest. The sensation caught fit and healthy Sam, 54, by surprise... (Source: the Mail online | Health)

Suicide Rates Among Cancer Patients Are Falling

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

THURSDAY, May 30, 2024 -- Even as suicide rates have risen among Americans generally, one group appears to be bucking that trend: People diagnosed with cancer. Experts are crediting improved access to counseling and other " psychosocial care " with... (Source: Drugs.com - Daily MedNews)

Cancer Patients Get Poorer Care at Hospitals Serving Minority Communities

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

THURSDAY, May 30, 2024 -- Cancer patients receive less effective treatment at hospitals that mainly serve minority communities, a new study shows.More than 9% of cancer patients are treated at hospitals where a significant percentage of patients... (Source: Drugs.com - Daily MedNews)

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

SÖDERTÄLJE, Sweden and SAN FRANCISCO and KYOTO, Japan, May 30, 2024 (GLOBE NEWSWIRE) -- Anocca AB (Anocca), a leading T-cell receptor-engineered T-cell (TCR-T) therapeutics company, and Shinobi Therapeutics (Shinobi), developer of immune-evasive induced pluripotent stem cell (iPSC)-derived CD8…#sweden #kyoto #anoccaab #anocca #shinobitherapeutics #shinobi #tcr #reaganjarvis #katana #combiningshinobi (Source: Reuters: Health)

Scancell Advances Cancer Trial with MHRA Nod

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Scancell Holdings (GB:SCLP) has released an update. Scancell Holdings plc has announced the MHRA’s approval to include an additional cohort in its ...#scancellholdings #sclp #scancellholdingsplc #mhra (Source: Reuters: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

ASCO Advises on CDK4/6 Inhibitors for Breast Cancer ASCO Advises on CDK4/6 Inhibitors for Breast Cancer

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

ASCO provided guidance on the use of abemaciclib and ribociclib in the adjuvant setting for patients with stages II and III breast cancer.MDedge News (Source: Medscape Hematology-Oncology Headlines)

RaySearch releases latest version of RayCare

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

RaySearch Laboratories has released the latest version of its RayCare oncology information system, RayCare 2024A. The system features interoperability with Varian TrueBeam linear accelerators and improvements in radiotherapy treatment management. The company highlighted that RayCare 2024A can reduce the number of manual actions needed when combined with the active workflow support and treatment and quality assurance scheduling capabilities in RayCare, as well as the deep integration with RayStation. Other feature updates in RayCare 2024A include enhancements and usability updates to patient chart and task management features, and support for more external systems interfaces. (Source: AuntMinnie.com Headlines)

Qure.ai to unveil lung care continuum at ASCO meeting

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Qure.ai will unveil its AI-powered lung cancer continuum at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, from May 31 to June 4.Qure.ai will unveil its lung care continuum at the ASCO annual meeting.Qure.aiThe end-to-end care continuum is designed to support clinicians and promote developments for lung health in the pharmaceutical and medical device industries. It features AI tools that identify, measure, manage, and monitor lung health developments. Examples of its capabilities include identifying missed lung nodules from chest x-rays and supporting early lung cancer diagnosis, as well as measuring lung nodules via CT scans and tracking volumetric growth, the company said. (Source: AuntMinnie.com Headlines)

EchoNous highlights study on Kosmos ultrasound system

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

EchoNous is highlighting the results of a study suggesting the company's Kosmos ultrasound system improves cardiac evaluations in chemotherapy patients. The study, published in the European Heart Journal, found that the ultrasound system allowed ultrasound practitioners of all experience levels to accurately and quickly assess left ventricular ejection fraction (LVEF), an indicator of heart health and a measure to monitor in patients undergoing chemotherapy treatment. The study involved 115 patients and had oncology staff perform heart scans using the Kosmos system. The findings showed that the nonultrasound experts achieved diagnostic accuracies between 89% to 94%. Kosmos is equipped with AI algorithms Trio and Kosmos Auto EF and guides users through the scanning process. The system als...

Zimbabwe: Ministry of Health Commits to Fighting Childhood Cancers

AllAfrica News: Health and Medicine — Thu, 06 Jun 2024 21:17:47 +0100

[The Herald] The Ministry and Child Care is committed to fighting childhood cancers through strategic partnerships. (Source: AllAfrica News: Health and Medicine)

MedWorm Message:

New research platform assesses brain cancer mutations during surgery

News from Mayo Clinic — Thu, 06 Jun 2024 21:17:47 +0100

JACKSONVILLE, Fla. — Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published in Proceedings of the National Academy of Sciences, Mayo Clinic researchers report on a new surgical platform used during surgery that informs critical decision-making about tumor treatment within minutes. Time is of the utmost importance when dealing with aggressive malignant tumors. The platform… (Source: News from Mayo Clinic)

Mayo Clinic Comprehensive Cancer Center to highlight key studies at ASCO 2024

News from Mayo Clinic — Thu, 06 Jun 2024 21:17:47 +0100

ROCHESTER, Minn. — Researchers from the Mayo Clinic Comprehensive Cancer Center are set to present key research findings, including two late-breaking abstracts, during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago May 31-June 4. These studies shed light on critical aspects of canc er treatment and management. Below are the highlights: The impact of adjuvant endocrine therapy (AET) omission in estrogen receptor (ER)-low (1%-10%) early-stage breast cancer (Abstract: 513) Presenter: Grace Choong,… (Source: News from Mayo Clinic)

The Sickening Reality of 'White' Beauty Standards

MedPage Today Psychiatry — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- Following the 2022 publication of the NIH's 10-year epidemiological study that found an association between hair straightening products and uterine cancer, thousands of Black women filed lawsuits alleging hair product companies... (Source: MedPage Today Psychiatry)

'Dance Moms' alum Kelly Hyland has been diagnosed with a 'fast-moving' breast cancer

L.A. Times - Health — Thu, 06 Jun 2024 21:17:47 +0100

Former reality television star Kelly Hyland discovered that she had malignant breast cancer after she noticed a lump in her breast and significant weight loss. (Source: L.A. Times - Health)

Bellus Academy Gives Back with Complimentary Compassionate Care Services in June

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

Compassion is a beautiful thing, and Cancer Survivor Beauty and Support Day observed on June 4, unites beauty professionals around the globe to channel their compassion into volunteer service supporting cancer patients and survivors. Bellus Academy is extending its support of this... (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Mom, 33, is diagnosed with deadly skin cancer after daughter, 2, thought mole was a chocolate stain

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Amanda Eilian, of New York, visited her doctor in 2010 after her child called the mole on her wrist a 'chocolate' stain. While a doctor initially dismissed it, the spot turned out to be melanoma. (Source: the Mail online | Health)

Smoking Isn't the Only Source of Nicotine Addiction in Town

MedPage Today Public Health — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- E-cigarettes were introduced in the early 2000s as a way for smokers to manage their nicotine addiction without exposing themselves to the well-documented harms associated with the toxins and carcinogens in combustible cigarette... (Source: MedPage Today Public Health)

Riordan Clinic receives $1-million donation earmarked for research, operations

bizjournals.com Health Care:Biotechnology headlines — Thu, 06 Jun 2024 21:17:47 +0100

Part of a $1-million donation to the north Wichita clinic will be in line with its work in holistic medical research and cancer care. (Source: bizjournals.com Health Care:Biotechnology headlines)

Tattoos May Increase Risk of Malignant Lymphoma

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

WEDNESDAY, May 29, 2024 -- Tattoo exposure is associated with an increased risk of several malignant lymphoma subtypes, according to a study published online in the June issue of eClinicalMedicine.Christel Nielsen, Ph.D., from Lund University in... (Source: Drugs.com - Pharma News)

' Be Your Own Expert': Interpreting Clinical Trial Data'Be Your Own Expert': Interpreting Clinical Trial Data

Medscape Today Headlines — Thu, 06 Jun 2024 21:17:47 +0100

High-profile oncologists don't always interpret clinical trials correctly. To understand new data, apply basic statistical principles yourself, says oncologist Bishal Gyawali, MD, PhD.Medscape Oncology (Source: Medscape Today Headlines)

MedWorm Message:

I was told I had cancer by EMAIL - cruel doctors didn't have decency to call me first

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Jamie Sweeney, 64, said her eyes filled with tears when she received the diagnosis via a message on her Ipad. The Ohio native is urging doctors to withhold the information. (Source: the Mail online | Health)

U.S. grants $6M to boost domestic supplies of isotopes

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The U.S. Department of Energy (DOE) has awarded $6 million in funding to nine organizations to advance medical isotope production research. Funded projects include work to develop new separation schemes for purifying rare isotope material for radioisotopes used in cancer treatments and designing a novel compact particle accelerator specifically for isotope production in university or hospital settings, the DOE said. The funding is part of a federal program that produces critical isotopes otherwise unavailable or in short supply in the U.S., noted Jehanne Gillo, director of the DOE Isotope Program, in a statement. “A vibrant research program in isotope production, enrichment, and radiochemistry is key to promoting U.S. independence from foreign supply chains of enabling isotopes,” sh...

AI predicts brain surgery outcomes on MRI

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

A machine-learning algorithm used with resting-state functional MRI can help clinicians foresee surgical outcomes in high-grade glioma patients, researchers have found. A team led by Patrick Luckett, PhD, of Washington University School of Medicine in St. Louis, MO, developed a random-forest classifier that was highly accurate for predicting tumor resection outcomes in brain cancer patients. The study results were published May 24 in the Journal of Neuro-Oncology. "The capability to forecast postsurgical functional outcomes from the initial diagnosis could prove advantageous in surgical planning and for better informing patients of their likely treatment outcomes," the group noted. High-grade glioma is the most common and fatal brain cancer of the central nervous system, accounting for ...

Frankenlimbs! Doctors are using 'spare parts' removed during ops to perform reconstructions on arms and legs following cancer surgery

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Surgeons who published a study on the revolutionary technique say such the technique could not only help patients it could also help beat record NHS waiting lists. (Source: the Mail online | Health)

Insurance barriers hinder access to screening as colon cancer rates rise

Health News - UPI.com — Thu, 06 Jun 2024 21:17:47 +0100

With the alarming rise of colorectal cancer diagnoses among Americans under 50, it is more important than ever for people to know their cancer risk and when to get screened. (Source: Health News - UPI.com)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Marriage may be more likely to save you from cancer than CHEMO, according to doctors

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

A study re-emerged this week claiming that married cancer patients are up to 33 percent less likely to die than those who are single, and marriage was up to 20 percent more effective than chemo. (Source: the Mail online | Health)

Cancer biotech lays off more employees in 2024, begins hunt for 'strategic options'

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

The company, which laid off workers in January, is slimming down its drug development work cutting more employees. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Diabetes May Affect Breast Cancer Care for Some Women Diabetes May Affect Breast Cancer Care for Some Women

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Low-income women with diabetes were less likely to receive adjuvant radiotherapy and chemotherapy to treat breast cancer compared with those without diabetes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

I'm a men's health expert - watch out for this little known sign of cancer in your genitals

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Dr Peter White, a urologist at Phallosan Health, is urging men to check their member more often - saying the penis is a window into the body's health. (Source: the Mail online | Health)

Diagnosis of Early-Onset Colorectal Cancer Often Delayed

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

WEDNESDAY, May 29, 2024 -- Nearly half of individuals diagnosed with early-onset colorectal cancer (EOCRC) present with hematochezia and abdominal pain and one-quarter present with altered bowel habits, according to a review published online May 24... (Source: Drugs.com - Pharma News)

MedWorm Message:

Doc Accused of Faking Cancer Dx; Out-of-Hospital C-Sections; Forced Sterilizations?

MedPage Today Public Health — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Doc Accused of Faking Cancer Diagnosis for Money A physician in Canada allegedly lied about... (Source: MedPage Today Public Health)

Chemo + Breast Cancer Combo Accelerates Functional Decline in Seniors

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

WEDNESDAY, May 29, 2024 -- The combination of breast cancer and chemotherapy contributes to accelerated functional decline in older women with early-stage breast cancer, according to a study published online April 28 in the Journal of Cancer... (Source: Drugs.com - Pharma News)

Class Action Suit Claims J & J Bankruptcy Filings Are Fraudulent

Asbestos and Mesothelioma News — Thu, 06 Jun 2024 21:17:47 +0100

A group of cancer patients are bringing a class action lawsuit against Johnson & Johnson. The suit alleges J&J’s Chapter 11 attempts are calculated tactics to avoid thousands of pending talcum powder lawsuits. The five plaintiffs filed their suit – Murphy et al. v. LTL Management Inc. et al., Case No.3:24-CV-06320 – in the U.S. District Court for the District of New Jersey. The lawsuit aims to represent any or all of the more than 50,000 people with pending J&J claims. Defendants include LTL Management Inc., the subsidiary created to hold and manage asbestos-contaminated talc legal claims against J&J. Additionally J&J corporate entities are named, as are J&J Chief Executive Officer Joaquin Duato. Kenvue Chief Executive Officer Thibaut Mong...

As one in five footballers admit to using trendy snus, experts warn the 'relaxing' nicotine pouches are highly addictive and have been linked to stroke, pancreatic and RECTAL cancer

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Nicotine pouches, also called snus, sees users place the pouches under their lip where it gradually releases nicotine into the mouth, which is in turn absorbed into the bloodstream. (Source: the Mail online | Health)

Highmark Members Save Significant Money on Outpatient Cancer Drug Available through CivicaScript

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

Highmark members are saving money on their generic oral oncology medication prescriptions through Highmark's leading role in a nationwide initiative to lower costs and boost access to generic medications. Highmark members taking abiraterone acetate, which is used to treat prostate cancer,... (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Trends in cancer-related suicide in the United States: a population-based epidemiology study spanning 40 years of data - Liu Q, Qu Z, Dong H, Qi Y, Wu J, Zhang W, Wang X, Wang Z, Fang Y, Wang J.

SafetyLit — Thu, 06 Jun 2024 21:17:47 +0100

Large cohort studies examining trends in cancer-related suicide are lacking. We analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database, encompassing a total of 4,870,410 patients diagnosed with cancer from 1975 to 2017 in the Un... (Source: SafetyLit)

FDA grants Priority Review to Roche ’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

Roche Investor Update — Thu, 06 Jun 2024 21:17:47 +0100

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2Additional analyses of INAVO120 will be presented in an oral abstract session at the 2024 American Society of Clinical Oncology Annual MeetingThe target action date for the FDA decision is 27November, 2024Basel, 29 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company ’s New Drug Application and granted Priority Review to inavolisib, an investigational, oral therapy, in combination with palbociclib (Ibrance®) and fulvestrant. The inavolisib-based regimen was evaluated in adult patients with PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor...

Could Tattoos Be Linked to Blood Cancer Risk?

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

WEDNESDAY, May 29, 2024 -- Research suggests that tattoo ink spurs inflammatory changes that might contribute to the development of lymphoma.The findings are early, however, and more study must be done to confirm any links between tattooing and the... (Source: Drugs.com - Daily MedNews)

Doctors May Have Tried to Treat Cancer in Ancient Egypt

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

WEDNESDAY, May 29, 2024 -- A 4,000-year-old skull provides evidence that ancient Egyptians might have tried to treat cancer, a new study claims.Microscopic observation of the skull revealed 30 or so lesions scattered across its surface that are... (Source: Drugs.com - Daily MedNews)

MedWorm Message:

Combo Therapy Boosts Survival for Advanced Colon Cancer

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

WEDNESDAY, May 29, 2024 -- People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds.A combination of two experimental immunotherapy drugs plus standard chemotherapy led to a median... (Source: Drugs.com - Daily MedNews)

Plant-Based Diets Lower The Risk Of Prostate Cancer

Forbes.com Healthcare News — Thu, 06 Jun 2024 21:17:47 +0100

Plant-based diets might help prevent prostate cancer from progressing. (Source: Forbes.com Healthcare News)

Ground-glass opacity on CT lung cancer imaging means better prognosis

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The presence of ground-glass opacities (GGO) rather than pure-solid nodules on CT lung cancer imaging is an encouraging prognostic factor in non-small cell lung cancer (NSCLC), researchers have reported. A team led by Meiling Li, MD, of Shanghai Jiao Tong University School of Medicine in China, found that minor-GGO elements on lung CT (equal to or less than 10%) were associated with a decreased likelihood of recurrence. The results were published May 29 in the American Journal of Roentgenology. "Among patients with clinical stage 1 NSCLC, cancers with a minor-GGO component were associated with a better prognosis versus those with a pure-solid appearance," the group noted. The presence of ground-glass opacities(GGO) is a favorable prognostic factor in NSCLC, but what has been less unders...

Weekend, evening mammo appointments may increase screening access

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Weekend and evening appointment availability for mammograms could improve screening access for women, according to research published May 24 in the Journal of the American College of Radiology. A team led by Joanna Rossi, MD, from Johns Hopkins University in Baltimore, MD, found that women who are younger than age 50, of a race other than non-Hispanic white, non-English speakers, and from less advantaged zip codes are more likely to attend weekend and evening screening mammography appointment times. “This data is in alignment with the increasing percentages of total screening mammograms scheduled on weekends or evenings at our institution since 2019 with implications that persistent and possibly increased demand exists in our population for screening appointments outside of normal busi...

Study Finds Intermittent Fasting Protects Against Liver Inflammation And Cancer

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Authored by Ayla Roberts via The Epoch Times (emphasis ours), A new study has found that intermittent fasting may protect against liver inflammation and even liver cancer. The study, conducted at the German Cancer…#aylaroberts #epochtimes #universityoftübingen #cellmetabolism #findingsexplained #caloric #franciscocontreras #mexico #carolinewalker #denton (Source: Reuters: Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

FDA Grants Accelerated Approval to Retevmo (selpercatinib) for Pediatric Patients Two Years and Older with RET-Altered Metastatic Thyroid Cancer or Solid Tumors

Drugs.com - New Drug Approvals — Thu, 06 Jun 2024 21:17:47 +0100

On May 29, 2024, the Food and Drug Administration granted accelerated approval to selpercatinib (Retevmo, Eli Lilly and Company) for pediatric patients two years of age and older with the following: advanced or metastatic medullary thyroid cancer... (Source: Drugs.com - New Drug Approvals)

Ancient Skull With Brain Cancer Preserves Clues to Egyptian Medicine

NYT Health — Thu, 06 Jun 2024 21:17:47 +0100

Cuts in the cranium, which is more than 4,000 years old, hint that people in the ancient civilization attempted to treat a scourge that persists today. (Source: NYT Health)

Gut bacteria could hold key to stopping spread of breast cancer, experts say

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

A team has been awarded £ 250,000 to investigate whether sufferers with certain gut bacteria fare better than others. (Source: Daily Express - Health)

Tattoos May Be a Risk Factor for Lymphoma

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- Tattoos may be a risk factor for malignant lymphoma, according to a Swedish population-based case-control study. Of nearly 12,000 people included in the study, those with tattoos had a higher risk of overall lymphoma compared... (Source: MedPage Today Hematology/Oncology)

Popular fashion retailer flagged for cancer-linked chemicals in products

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Popular online fast-fashion retailer Shein has been flagged by authorities in Seoul, South Korea, for having high levels of toxic chemicals in a plethora of its products, including items for children. In its latest round of inspections, Seoul authorities inspected 93 of Shein’s products and found…#seoul #shein #parksangjin #afp #thestreet #clothes #abcserrano #spain #greenpeacegermany #nanjing (Source: Reuters: Health)

MedWorm Message:

US FDA Approves Amgen's Biosimilar to AstraZeneca's Rare Blood Disorder Treatment US FDA Approves Amgen's Biosimilar to AstraZeneca's Rare Blood Disorder Treatment

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood disorder treatment Soliris.Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)

Living Outside of Comprehensive Cancer Center Catchment Area Tied to Later-Stage Diagnosis

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, May 28, 2024 -- Disadvantaged populations and those living outside of a comprehensive cancer center's main catchment area have higher odds of receiving a diagnosis of late-stage cancer, according to a study published online May 2 in JAMA... (Source: Drugs.com - Pharma News)

Stigma of prostate cancer leads to delayed screenings, diagnoses

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 06 Jun 2024 21:17:47 +0100

Prostate cancer is as common in men as breast cancer is in women, but it's not nearly as openly discussed. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Telix submits NDA for new prostate cancer imaging kit

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Telix Pharmaceuticals has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for a new prostate-specific membrane antigen (PSMA)-PET cold kit for prostate cancer imaging. Called TLX007-CDx, the kit enables more flexible production, including with gallium-68 (Ga-68) sourced from both newer high-activity generators and cyclotrons powered by ARTMS’ Quantm irradiation system and GE HealthCare’s FASTlab solid and liquid target production system. The new kit is expected to further expand the availability, distribution, and scheduling flexibility of PSMA-PET imaging, Telix said. (Source: AuntMinnie.com Headlines)

I'm an oncologist whose mom has lung cancer. Here's what to do as soon as you or a loved one is diagnosed

the Mail online | Health — Thu, 06 Jun 2024 21:17:47 +0100

Dr Mikkeal A Sekeres, chief of the division of hematology at Sylvester Comprehensive Cancer Center in Miami, shared with the Washington Post his top tips for navigating a new cancer diagnosis. (Source: the Mail online | Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

For Cancer Patients Facing Infertility, Access to IVF Is Paramount

MedPage Today OB/GYN — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- Reproductive autonomy is under threat across the U.S., affecting not just access to abortion but a host of other health services. A proposal by lawmakers has the potential to grant greater reproductive autonomy for federal workers... (Source: MedPage Today OB/GYN)

Cancer Is Capsizing Americans' Finances.'I Was Losing Everything. '

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

(Source: Reuters: Health)

The Massive Deal That Could Send This Biotech Into A Break Out

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

Agios Pharmaceuticals (AGIO) agreed Tuesday to sell its 15% royalty in a brain cancer drug to Royalty Pharma (RPRX) for $905 million upfront. Agios stock rose sharply at the opening bell. Under the terms of the deal, Agios will sell its royalty on potential U.S. net sales of Servier's vorasidenib…#agiospharmaceuticals #royaltypharma #agios #servier #marketsurge #allisongatlin #ibdagatlin #untapped (Source: Reuters: Health)

A Life in Medical Innovation and Philanthropy

MedPage Today Hematology/Oncology — Thu, 06 Jun 2024 21:17:47 +0100

(MedPage Today) -- "The Doctor's Art" is a weekly podcast that explores what makes medicine meaningful, featuring profiles and stories from clinicians, patients, educators, leaders, and others working in healthcare. Listen and subscribe/follow... (Source: MedPage Today Hematology/Oncology)

The Health Scare that Pushed Jonathan Yeo to Paint, and Why King Charles Had Him Seeing Red

Reuters: Health — Thu, 06 Jun 2024 21:17:47 +0100

The royal portraitist wasn’t sure he’d end up a painter, but a cancer diagnosis changed everything. ‘I’m not sure I would have had the determination.’ (Source: Reuters: Health)

MedWorm Message:

Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study published online May 27 in Cancer. Edoardo Beatrici, M.D., from Brigham and... (Source: Drugs.com - Pharma News)

Omission of SLNB Feasible for Younger Patients With ER+/cN0 Breast Cancer

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, May 28, 2024 -- A novel natural language understanding (NLU) pipeline can identify the rates of lymphedema and node positivity among women with estrogen receptor-positive (ER+), clinically node-negative (cN0) breast cancer, according to a... (Source: Drugs.com - Pharma News)

June 2024

NIH News in Health — Thu, 06 Jun 2024 21:17:47 +0100

Beyond Basic Blood Tests : A Window Into Your Health Green Spaces May Improve Kids ’ Mental Health The Mighty Fruit Fly : Pesky Insects Give Clues to Our Health Spirituality in Cancer Care and Serious Illness How Medications and Supplements Interact (Source: NIH News in Health)

Hereditary Amyloidosis May Mask as Diabetic Neuropathy Hereditary Amyloidosis May Mask as Diabetic Neuropathy

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Delayed diagnosis of hereditary amyloidosis can lead to serious nerve or heart damage. Dr Morie Gertz highlights red flags that suggest HA and discusses appropriate therapies.Medscape (Source: Medscape Hematology-Oncology Headlines)

ASCO: Conjugated Equine Estrogen May Increase Risk for Ovarian Cancer

Drugs.com - Pharma News — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, May 28, 2024 -- Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study presented at the annual meeting of the American Society of Clinical... (Source: Drugs.com - Pharma News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Global oncology trends 2024: outlook to 2028

The Kings Fund - Health Management Specialist Collection — Thu, 06 Jun 2024 21:17:47 +0100

IQVIA Institute for Human Data Science - Latest estimates indicate that the number of patients affected by cancer will increase dramatically through the middle of the century across all regions of the world. At the same time, the innovation ecosystem that discovers, develops, and delivers breakthrough therapies in entire new areas of science is operating near peak levels. Rising incidence, increasing numbers of treated patients, and the resulting expected growth in spending in this area will trigger an array of complex challenges over the next several years that are reflected in the trends highlighted in this report.ReportMore detail (Source: The Kings Fund - Health Management Specialist Collection)

A connection between phosphatidylinositol 5-phosphate and the Hippo pathway to prevent epithelial-mesenchymal transition in cancer | Science Signaling

Signal Transduction Knowledge Environment — Thu, 06 Jun 2024 21:17:47 +0100

The phosphoinositide PI5P inhibits YAP-mediated EMT (Palamiuc et al., in 28 May 2024 issue). (Source: Signal Transduction Knowledge Environment)

Obesity and Cancer: Untangling a Complex Web Obesity and Cancer: Untangling a Complex Web

Medscape Hematology-Oncology Headlines — Thu, 06 Jun 2024 21:17:47 +0100

Although more than 40% of cancers are considered obesity-related, excess weight is often just a contributing risk factor, leaving uncertainty about the role weight plays in cancer risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)

Six of the most important red flag signs of cancer you shouldn't ignore

Daily Express - Health — Thu, 06 Jun 2024 21:17:47 +0100

If you experience any of these unexplained symptoms you should speak to your doctor, experts said. (Source: Daily Express - Health)

Novita to Present First-in-Class Fascin Inhibitor NP-G2-044 Phase 2 Results in Patients with Advanced and Metastatic Solid Tumors at 2024 ASCO Annual Meeting

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

Novita Pharmaceuticals, Inc. ("Novita" or the "Company"), a privately held clinical-stage pharmaceutical company dedicated to developing novel cancer drugs based on its proprietary fascin inhibitor technology platform, announced today that it will present the Phase 2 clinical trial... (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message:

CancerIQ Co-founder Receives Medal of Honor for Achievements in Breast Cancer Prevention and Early Detection

PRWeb: Medical Pharmaceuticals — Thu, 06 Jun 2024 21:17:47 +0100

Dr. Olopade acceptance of Ellis Island Medal of Honor coincides with publication of her team's landmark study on breast cancer risk in women of African and Caribbean descent CHICAGO, May 28, 2024 /PRNewswire-PRWeb/ -- CancerIQ, a best-in-class precision health platform for cancer... (Source: PRWeb: Medical Pharmaceuticals)

Strategy Could Expand Stem Cell Donor Pool for People Battling Blood Cancers

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, May 28, 2024 -- An older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant, a new study finds.The drug, cyclophosphamide, could help patients... (Source: Drugs.com - Daily MedNews)

Strategy with Cyclophosphamide Could Expand Stem Cell Donor Pool for People Battling Blood Cancers

Drugs.com - Daily MedNews — Thu, 06 Jun 2024 21:17:47 +0100

TUESDAY, May 28, 2024 -- An older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant, a new study finds. The drug, cyclophosphamide, could help patients... (Source: Drugs.com - Daily MedNews)

ChatGPT tested on cardiac imaging questions

AuntMinnie.com Headlines — Thu, 06 Jun 2024 21:17:47 +0100

In this study, the researchers assessed the feasibility of using ChatGPT as a resource to educate patients on various aspects of cardiac imaging, including diagnosis, imaging modalities, indications, interpretation of radiology reports, and management. The group posed 30 questions to ChatGPT-3.5 and ChatGPT-4 three times in three separate chat sessions. The responses were scored as correct, incorrect, or clinically misleading by two cardiologists and one radiologist, with categorization based on majority vote. Questions ranged from those on simple diagnostic subjects (“My doctor wants to run tests to diagnose coronary artery disease. What tests will be ordered?”) to more complex report interpretations (“I received a CAD-RADS-2 category on my coronary CT report, what does this mean?...